hg_200818.1

Basic information about the TSS

---

TSS ID: hg_200818.1 Species: human Chr: chrX		Start: 149505243 End: 149505263 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BX647357 Distance: 0 GeneID: 3423 HGNC/MGI_ID: HGNC:5389 UniProt_ID:

Gene_name: iduronate 2-sulfatase Gene_symbol: IDS Gene_synonyms: ID2S Gene_source: HGNC:5389

TATA-Box annotation

---

Distance to TSS:	53
Nearest PromoterID:	NM_000202
Entrez ID:	3423
Nearest Unigene:	Hs.6795
Nearest Refseq:	NM_000202
Nearest Ensembl:	ENSG00000010404
Gene Name:	iduronate 2-sulfatase
Gene Alias:	MPS2|SIDS
Gene Description:	iduronate 2-sulfatase
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.741294
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@IDS p2@IDS p3@IDS p4@IDS p5@IDS p6@IDS p7@IDS p9@IDS p10@IDS
Sample		p1@IDS	p2@IDS	p3@IDS	p4@IDS	p5@IDS	p6@IDS	p7@IDS	p9@IDS	p10@IDS
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	26.88	3.51	1.75	0.19	0.39	0.39	0.78	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.78	3.03	1.01	0.40	0.40	0.81	1.21	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.62	2.51	2.12	0.39	0.19	0.19	1.35	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.11	4.99	1.04	0.42	0.21	0.42	0.83	0.00	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	24.07	2.47	0.45	0.45	0.00	0.22	0.45	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	24.61	3.88	1.36	0.58	0.19	0.39	0.58	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	28.54	3.49	2.40	0.65	0.22	0.00	1.96	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	29.79	2.66	1.21	0.24	0.48	0.48	0.73	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.78	4.27	1.07	0.21	0.21	0.85	0.85	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	27.24	1.16	0.58	0.00	0.58	0.00	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	27.08	2.43	0.81	0.00	0.00	0.00	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	2.85	0.81	0.00	0.00	0.41	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	62.38	10.48	2.58	1.13	0.81	0.64	3.39	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	53.37	7.82	1.80	1.05	0.90	0.90	2.71	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	49.18	8.56	0.88	0.66	0.66	0.00	1.54	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	48.29	10.56	5.28	1.76	1.76	0.75	3.27	1.01	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	43.24	7.64	2.84	0.87	1.97	0.22	1.75	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	57.79	9.70	6.75	2.53	1.69	1.27	5.91	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	33.59	5.86	5.86	3.20	0.00	0.53	1.60	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	52.65	7.52	2.56	1.05	0.75	0.60	2.41	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	51.72	8.69	3.07	1.87	2.14	0.67	2.41	0.27	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	49.72	8.11	1.90	0.86	1.73	0.52	2.59	0.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.79	6.20	2.84	1.29	1.16	0.65	2.59	0.65	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	51.20	8.01	2.43	0.97	2.43	0.73	2.18	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	48.24	7.74	1.81	1.03	1.03	0.77	3.87	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	50.33	5.06	3.17	1.58	0.95	0.00	1.58	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	53.85	7.69	3.85	1.10	3.85	0.00	3.85	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	61.06	9.67	2.59	0.24	1.41	0.47	1.18	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	49.10	7.91	5.49	0.81	1.45	0.97	2.91	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	52.66	5.79	1.81	1.63	1.27	0.54	3.08	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	52.55	7.75	2.93	2.09	1.88	0.84	4.19	0.42	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.99	8.40	2.93	1.17	1.76	0.39	3.71	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	47.06	7.60	10.76	3.59	3.59	0.63	4.85	1.27	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.33	5.11	5.44	2.47	1.48	0.66	3.63	0.99	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	46.93	8.79	2.99	1.12	2.80	0.00	3.18	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	53.46	8.43	3.64	0.77	1.92	1.15	4.60	0.38	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	46.19	7.36	5.31	1.43	3.47	1.23	4.09	0.41	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	50.77	9.07	3.83	0.60	3.22	0.20	1.41	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	48.35	11.07	2.70	0.81	0.27	0.54	2.70	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	51.61	7.20	2.64	0.72	0.24	0.96	3.60	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	47.05	6.59	1.41	0.71	2.59	0.24	2.12	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	36.31	6.88	3.81	0.88	1.46	0.29	3.22	0.15	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	55.68	6.54	2.95	1.27	1.05	0.84	3.80	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	60.14	11.19	4.37	1.57	1.40	1.40	3.85	0.00	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	59.63	9.64	1.81	0.40	1.61	0.80	1.41	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	54.21	10.24	3.49	2.09	2.56	0.93	3.95	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	55.42	8.64	2.88	2.16	3.12	0.24	3.60	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	62.59	9.54	4.77	0.89	0.89	0.60	2.98	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	66.79	7.66	3.11	0.48	1.91	0.96	3.35	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	58.03	9.91	3.24	1.01	0.81	0.61	2.63	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	68.25	10.04	4.71	1.64	1.43	0.61	5.74	0.20	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	79.17	14.23	6.45	2.00	2.67	1.56	6.00	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	41.98	13.99	13.99	0.00	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	102.91	12.77	3.55	2.48	1.77	2.84	2.48	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	78.21	10.60	3.65	0.99	1.33	0.66	0.66	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	2.52	31.88	8.39	0.84	0.00	28.52	1.68	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	23.42	3.21	6.89	2.76	1.84	0.46	10.56	0.92	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	97.88	11.34	2.92	0.97	3.57	1.62	1.30	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	99.56	15.42	4.18	1.28	3.85	0.32	2.89	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.12	3.14	9.43	2.83	2.83	2.51	9.74	2.20	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	109.99	18.33	0.00	1.41	2.82	1.41	2.82	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	93.09	23.55	2.24	0.56	2.24	1.68	2.24	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	21.50	2.39	31.85	12.74	5.57	2.39	20.70	3.18	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	36.02	6.12	11.55	3.40	5.44	0.68	7.14	1.70	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	110.15	15.27	4.87	1.95	2.27	2.60	1.62	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	99.04	20.23	3.19	4.97	2.13	0.35	3.19	0.35	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	48.49	0.00	0.00	0.00	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	23.69	7.90	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	107.25	18.53	3.41	0.98	6.34	0.49	2.44	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	101.65	21.32	5.45	0.50	3.47	2.48	1.98	1.98	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	80.69	13.60	4.69	0.47	1.88	0.00	2.35	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	57.30	10.27	5.63	0.99	3.31	0.66	7.62	0.99	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	120.33	20.42	1.86	1.24	2.17	1.55	3.71	0.62	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	137.89	26.29	3.97	2.14	2.75	0.92	3.36	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	36.90	9.34	0.32	0.48	0.00	0.16	0.00	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	22.78	5.45	1.60	0.64	0.16	0.16	1.12	0.48	0.00
Adipocyte - omental, donor1	11473-119C6	27.23	6.23	1.15	0.25	0.25	0.25	0.25	0.76	0.13
Adipocyte - omental, donor2	11474-119C7	23.92	8.97	2.99	1.49	0.75	1.49	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	16.41	2.68	1.00	0.00	0.00	0.33	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	31.90	6.38	1.28	0.64	0.00	0.64	0.64	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	20.32	4.52	0.00	0.45	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	16.51	1.39	0.00	0.00	0.17	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	29.73	8.21	0.59	0.00	0.00	0.20	0.00	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	22.91	4.63	0.00	0.00	0.00	0.00	0.00	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	26.48	8.08	1.12	0.28	0.28	0.00	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	14.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	22.84	4.58	0.08	0.16	0.00	0.16	0.00	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	21.62	6.46	1.61	0.00	0.65	0.32	0.32	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	24.53	4.80	0.53	0.00	0.53	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.59	3.90	0.56	0.56	0.56	0.00	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.47	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	23.36	4.77	0.25	0.00	0.25	0.00	0.00	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	24.22	5.56	1.31	0.00	0.00	0.33	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	17.66	2.74	0.61	0.00	0.30	0.00	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	32.93	4.86	0.44	0.44	0.00	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	18.29	6.10	0.00	0.36	0.00	1.43	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.41	7.56	0.00	0.00	0.18	0.00	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	13.35	5.34	0.21	0.00	0.21	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	23.34	3.66	0.57	0.23	0.00	0.23	0.23	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	27.18	5.39	0.24	0.00	0.00	0.24	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.38	12.13	0.90	0.00	0.00	0.90	1.35	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	12.59	1.74	0.43	0.43	0.87	3.91	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	10.70	2.14	0.00	2.14	0.00	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.35	11.36	1.49	0.30	1.49	0.90	0.90	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	7.59	5.06	1.26	0.00	1.26	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	9.90	0.00	0.00	0.00	0.00	1.98	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.27	13.65	1.95	0.97	0.97	0.65	1.30	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.56	12.62	1.94	0.97	0.97	0.00	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.25	7.72	0.59	1.19	2.38	0.00	1.19	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.83	9.42	1.51	0.00	0.75	0.00	1.51	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	15.96	2.90	1.45	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	10.03	2.51	0.00	0.00	0.00	0.00	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.44	10.87	0.99	0.16	0.16	0.33	0.00	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	6.82	1.36	1.36	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.84	11.61	0.30	0.45	0.30	0.00	0.15	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	12.86	2.68	0.54	0.54	0.00	1.61	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.35	9.64	1.13	0.57	0.19	0.38	0.57	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.58	10.16	2.14	0.80	0.27	0.00	1.07	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	10.73	0.98	0.00	0.98	0.98	2.93	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.91	10.78	1.16	0.00	0.00	0.50	0.33	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	6.00	0.00	1.20	0.00	0.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	17.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	22.30	10.81	1.89	0.00	1.03	0.51	0.17	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	25.17	0.00	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.48	14.08	2.43	0.00	0.97	0.97	3.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.97	12.52	2.28	0.38	0.38	0.38	0.00	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	18.17	1.21	0.00	1.21	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	15.96	1.71	0.00	0.57	1.14	1.14	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.94	8.76	1.28	0.00	0.86	0.86	1.07	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	15.49	10.32	0.52	0.26	0.26	1.03	0.26	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.01	12.20	0.94	0.00	0.00	0.00	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.87	12.22	2.89	0.64	0.00	0.32	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	12.84	0.71	0.00	0.00	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.28	11.70	1.75	0.58	0.58	0.58	0.58	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.87	11.14	1.20	0.60	0.30	0.90	1.20	0.00	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	20.20	13.07	1.19	1.19	1.19	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.70	11.19	2.54	1.02	1.02	0.00	2.03	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.38	10.70	2.04	1.53	0.76	0.25	1.53	0.25	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	9.53	1.27	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.95	7.34	1.73	0.00	0.00	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.03	9.95	0.85	0.64	1.06	0.00	1.06	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.50	6.96	0.58	0.29	0.29	0.29	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	9.45	0.94	0.94	0.00	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.80	10.00	0.68	0.34	0.34	0.00	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	9.27	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	10.56	2.11	0.00	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	21.87	9.65	1.07	0.86	0.43	0.64	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.85	14.44	1.80	0.00	0.00	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	6.56	0.73	1.46	0.00	0.73	0.00	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.71	11.95	0.92	0.23	0.69	0.69	1.84	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	10.20	5.10	0.00	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.37	9.41	0.25	0.25	0.51	0.25	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.52	11.56	1.86	0.41	1.03	0.41	0.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.52	10.40	0.92	0.31	0.31	0.31	0.92	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	14.82	15.77	2.87	0.48	0.00	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.73	10.87	2.44	0.00	0.22	0.22	0.44	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	10.68	1.53	1.53	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.85	9.97	0.55	1.11	0.00	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	17.74	12.18	1.32	0.53	0.26	1.06	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.17	9.09	0.36	0.36	0.36	0.36	1.09	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	21.25	3.07	0.25	0.49	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	22.42	4.45	0.34	0.00	0.00	0.17	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	27.06	3.57	0.21	0.00	0.00	0.21	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	48.45	10.46	1.05	0.00	0.00	0.35	1.39	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	49.18	5.82	1.62	0.81	0.32	0.49	1.94	0.32	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	55.49	7.01	1.19	0.15	0.45	0.45	0.30	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	74.66	4.36	2.18	0.57	1.26	0.69	0.46	0.34	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	75.29	5.26	0.88	0.75	0.75	0.25	0.63	0.38	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	66.23	3.30	1.48	0.57	0.80	0.57	0.00	0.34	0.00
Basophils, donor1	12241-129G9	104.09	47.86	0.26	0.00	0.26	3.40	0.00	0.00	0.00
Basophils, donor2	12242-129H1	149.37	57.73	0.72	0.72	0.00	7.94	1.08	0.00	0.72
Basophils, donor3	12243-129H2	155.52	61.30	0.73	0.59	0.00	2.79	0.44	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	14.88	8.41	0.43	0.00	0.00	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	14.63	6.86	0.00	0.00	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	1.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	14.76	4.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	14.28	2.76	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	18.17	6.12	0.90	0.54	0.54	0.18	0.90	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	50.50	6.70	1.96	0.31	0.62	0.10	0.82	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	101.08	12.81	2.56	0.93	0.93	3.03	0.23	0.70	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	93.69	22.38	0.00	0.00	0.32	0.96	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	88.48	29.30	0.56	0.56	0.56	1.13	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	112.85	36.75	2.23	0.93	0.56	2.23	0.56	0.56	0.37
CD14+ Monocytes, donor3	11381-118B4	165.09	53.13	2.41	1.10	0.66	1.10	0.66	0.00	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	54.91	9.62	0.28	0.00	0.00	0.57	0.28	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	62.17	18.95	0.76	0.38	0.38	0.38	0.00	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	61.80	15.78	1.64	0.00	0.00	0.33	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	198.03	73.86	9.54	2.17	3.32	5.93	3.32	1.45	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	178.03	47.07	2.11	2.41	0.30	4.83	1.81	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	271.01	76.04	5.45	2.13	0.71	6.87	2.13	1.90	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	111.65	51.22	5.86	2.85	1.34	4.18	1.34	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	136.63	36.99	2.48	0.83	1.38	3.31	1.38	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	162.39	44.13	4.46	1.98	0.99	2.48	0.50	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	85.96	39.36	3.52	0.59	1.37	1.76	1.37	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	105.40	41.31	0.89	2.14	0.71	2.14	1.60	0.53	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	116.21	32.86	0.87	0.22	0.22	2.83	1.31	0.44	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	89.44	36.52	2.11	0.70	0.94	1.40	0.23	0.70	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	109.30	31.68	1.58	0.53	0.53	2.11	1.06	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	108.72	34.39	2.22	0.00	1.11	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	146.07	55.04	6.69	2.83	1.78	4.02	2.38	1.34	1.78
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	147.47	45.50	2.79	1.60	0.60	4.79	2.20	1.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	136.79	47.26	2.71	2.08	0.42	2.50	1.67	0.21	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	163.58	58.80	4.58	1.37	2.06	5.26	3.89	1.14	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	109.71	42.53	3.62	0.90	0.00	2.49	0.68	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	168.91	56.30	3.06	0.87	1.75	4.80	0.44	1.31	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	113.51	53.26	3.50	0.81	0.00	3.77	2.15	1.61	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	163.82	52.86	5.23	0.70	0.35	5.06	1.92	0.70	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	187.69	64.39	4.21	1.26	0.84	4.21	1.26	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	96.63	32.70	6.06	1.65	1.29	2.39	2.94	0.55	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	102.51	29.24	1.76	1.41	0.35	0.70	1.06	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	140.83	39.49	2.19	2.19	0.44	4.39	2.19	1.32	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	77.42	26.85	3.66	1.22	0.70	1.22	1.92	1.05	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	100.35	31.96	4.46	1.49	0.37	2.60	1.49	1.12	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	112.95	37.51	1.51	0.86	0.22	3.23	0.86	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	89.27	29.48	4.50	1.23	0.41	2.46	2.46	2.05	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	72.78	24.57	0.70	0.00	0.46	1.62	0.46	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	122.96	35.73	1.62	0.46	0.46	2.09	0.93	0.46	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	38.36	18.74	0.87	0.22	0.00	1.53	0.44	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	43.43	19.17	1.62	0.00	0.23	0.23	0.46	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	34.23	15.81	0.00	0.22	0.22	0.22	0.22	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	66.96	45.32	1.40	0.62	0.31	0.93	0.62	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	62.87	33.36	1.57	0.52	0.70	0.17	0.87	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	90.75	46.82	0.89	0.45	0.45	0.45	0.67	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	51.55	28.07	0.26	0.51	0.00	0.26	0.26	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	56.21	26.57	0.88	0.22	0.44	1.32	0.44	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	60.43	21.90	1.26	0.21	0.21	0.42	0.84	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	10.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	52.88	6.10	0.00	0.00	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	42.46	8.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	55.44	6.93	0.53	0.53	0.00	0.00	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	51.46	5.90	0.00	0.00	0.54	0.54	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	51.94	4.21	0.70	0.70	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.90	9.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	47.46	1.32	0.00	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	227.67	30.41	3.29	0.82	0.82	3.29	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	253.17	26.12	0.73	0.73	0.00	4.35	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	255.44	29.78	3.03	1.51	1.01	3.03	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.14	1.62	0.00	0.00	0.00	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.78	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	122.49	29.12	1.00	1.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	85.96	40.45	2.25	0.56	1.12	2.81	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	40.58	10.15	0.00	0.38	0.38	0.00	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	35.18	8.12	0.23	0.23	0.00	0.68	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	467.74	163.53	2.86	1.43	2.86	8.57	1.07	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	398.04	127.37	9.80	2.45	6.74	9.80	7.35	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	381.24	111.02	4.27	1.22	2.13	4.57	2.44	0.61	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	58.70	13.02	1.02	0.26	0.51	2.55	0.51	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.28	13.93	1.12	0.45	0.90	0.22	0.45	0.45	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	86.81	13.51	0.86	0.29	0.57	0.29	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	120.42	45.51	0.95	0.00	0.47	0.00	0.47	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	96.92	30.90	0.70	0.00	0.00	0.70	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	112.07	32.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	68.93	21.82	1.30	0.43	0.58	1.45	0.87	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	95.58	15.93	4.24	2.20	1.19	1.36	1.86	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	83.18	17.73	2.90	1.29	1.29	1.77	1.13	0.48	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	98.63	40.35	0.90	0.00	0.45	0.90	0.90	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	104.82	34.94	1.05	0.00	0.35	1.40	0.70	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	123.19	37.40	2.64	0.88	0.88	1.76	3.08	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	36.26	6.75	2.11	0.42	0.00	0.00	0.84	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	48.62	7.48	1.45	1.25	0.42	0.62	1.04	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	38.76	5.01	1.67	0.67	0.00	0.00	1.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	140.05	45.68	1.63	0.54	0.00	1.63	0.54	0.82	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	137.20	41.80	2.14	0.00	0.00	1.61	2.14	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	111.18	19.73	5.38	0.00	0.00	1.79	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	56.18	17.62	0.37	0.56	0.00	0.74	0.37	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	73.43	16.03	1.52	0.87	0.22	1.30	1.08	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	96.46	23.54	1.05	1.05	0.42	0.84	0.63	0.42	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	136.51	56.12	1.01	0.51	0.51	1.52	0.51	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	158.57	51.56	0.87	0.00	0.43	3.90	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	193.07	67.55	7.41	0.44	0.87	3.05	1.74	2.18	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	95.01	21.28	0.00	0.49	0.99	0.49	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	94.16	28.62	0.00	0.00	1.85	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	103.29	12.56	0.00	0.00	0.00	1.40	1.40	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	67.29	35.45	0.55	0.55	0.55	0.28	1.38	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	78.77	36.56	3.68	0.00	0.25	0.25	1.96	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	97.02	24.64	0.00	0.00	0.00	0.00	1.54	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	107.08	27.93	0.36	0.00	0.36	0.36	0.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	98.33	29.08	0.00	0.00	0.00	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	409.24	186.62	1.64	0.98	0.33	11.13	1.31	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	390.45	138.91	9.76	4.13	1.50	11.26	4.13	1.50	1.88
CD8+ T Cells, donor3	11383-118B6	492.61	147.20	7.83	2.52	3.03	7.07	2.52	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	68.82	6.88	1.61	1.15	0.92	0.69	1.15	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	48.65	7.43	3.35	0.72	0.72	0.72	0.48	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	54.72	6.29	3.83	0.82	0.82	0.27	2.74	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	39.93	7.21	0.60	0.60	0.60	0.90	1.50	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	63.12	7.68	1.44	1.68	0.72	0.48	0.72	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	64.58	8.41	1.82	0.91	0.45	0.23	0.91	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	63.23	5.00	1.30	1.09	0.65	0.00	0.65	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	62.38	5.00	1.05	0.53	1.32	0.53	0.79	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	55.11	3.05	1.88	0.23	0.94	0.23	1.88	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	61.28	8.15	2.72	0.60	0.60	0.91	2.11	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	53.16	6.39	3.20	1.16	1.16	0.58	1.74	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	65.81	4.80	1.60	0.27	0.53	0.00	0.53	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	75.29	6.13	0.00	0.44	0.44	0.88	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	73.78	7.29	0.91	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	99.20	8.20	2.24	0.00	0.75	0.00	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	71.67	8.28	0.00	0.72	0.00	1.80	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	65.31	8.92	1.44	0.58	0.58	0.29	0.58	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	59.87	6.36	1.41	0.47	0.24	0.94	0.71	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	62.43	6.97	1.27	0.63	0.32	0.32	0.63	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	67.36	6.77	1.23	0.92	0.62	0.92	0.92	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	68.93	4.17	0.96	0.32	0.64	0.32	0.00	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	65.02	6.50	0.38	0.00	0.76	0.38	1.15	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	69.36	4.34	0.79	0.00	0.79	0.79	0.79	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	57.49	6.05	1.51	2.27	0.00	0.76	2.27	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	67.45	5.62	0.80	0.00	0.00	0.80	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	53.86	4.90	0.00	0.00	0.00	0.00	2.10	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	78.14	5.01	0.00	1.00	0.00	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.85	1.48	0.00	0.00	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	17.36	2.53	0.00	0.00	0.00	0.00	0.11	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	53.73	37.79	2.43	2.08	0.35	0.69	1.39	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	37.31	12.79	0.00	0.00	0.00	0.00	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	48.70	15.02	3.53	1.37	1.14	0.57	1.82	0.34	0.34
Chondrocyte - re diff, donor2	11339-117F7	86.84	37.60	0.90	0.00	0.00	4.48	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	84.52	27.10	2.43	1.21	1.21	0.00	1.62	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	42.69	6.08	1.03	0.23	0.23	0.23	0.11	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	39.12	7.05	0.64	0.43	0.43	0.43	1.28	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	56.55	7.52	1.59	0.44	0.44	0.62	0.44	0.27	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	152.22	22.93	2.02	0.73	1.19	1.10	0.46	0.09	0.28
Corneal Epithelial Cells, donor1	11526-119I5	10.76	3.95	0.00	0.00	0.00	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	4.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.29	6.14	0.00	0.00	0.51	0.51	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	53.99	16.84	0.99	0.17	0.17	0.50	0.83	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	56.46	14.82	0.63	0.32	0.32	0.32	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	10.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	51.30	9.40	1.30	0.22	0.65	0.43	0.43	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	132.22	69.01	1.02	0.68	0.00	1.37	0.68	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	103.15	41.78	0.00	0.00	0.00	3.26	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	98.24	72.11	0.00	0.48	0.00	2.42	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	24.35	4.00	0.00	0.00	0.00	0.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	5.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	24.60	7.35	0.28	0.28	0.28	0.00	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	21.63	4.33	0.00	0.00	0.39	0.00	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	29.38	4.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	32.94	5.18	0.00	0.24	0.24	0.94	0.94	0.00	0.71
Endothelial Cells - Artery, donor3	11413-118E9	24.54	3.51	0.00	0.00	0.00	0.35	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.27	4.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	22.21	6.09	0.91	0.30	0.30	0.30	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.75	7.33	0.56	0.56	0.00	0.28	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	16.94	3.27	0.89	0.00	0.59	0.00	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	24.99	4.69	0.52	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	21.98	3.12	0.14	0.00	0.14	0.28	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	20.01	9.20	0.80	0.00	0.40	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	30.92	7.34	1.05	0.00	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.10	2.36	0.62	0.25	0.00	0.25	0.00	0.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.47	0.87	0.00	0.22	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	30.53	2.56	0.12	0.12	0.00	0.00	0.00	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	20.48	2.28	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.26	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	42.08	4.71	0.16	0.16	0.16	0.63	0.00	0.16	0.00
Eosinophils, donor1	12244-129H3	76.23	76.23	0.00	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	613.90	140.27	4.95	4.95	0.00	14.85	3.30	0.00	1.65
Eosinophils, donor3	12246-129H5	588.53	124.84	10.70	14.27	3.57	3.57	3.57	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	8.06	0.24	0.00	0.24	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	63.63	19.29	2.05	0.82	1.23	0.82	1.64	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	41.50	14.01	1.75	0.22	0.88	2.08	1.09	0.22	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	51.35	3.14	3.58	0.43	2.17	0.22	3.14	0.11	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	41.36	10.55	1.09	0.73	0.49	0.97	0.36	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	29.20	19.79	0.55	0.41	0.27	0.14	0.14	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	38.71	10.86	2.64	0.63	0.53	0.74	0.42	0.53	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.08	24.24	0.79	0.26	0.00	0.26	0.26	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	43.19	8.30	0.66	1.00	0.66	0.00	1.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	17.24	4.54	0.91	0.00	0.00	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	31.83	6.82	0.00	0.00	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	52.83	14.19	0.63	0.32	0.32	0.63	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	25.16	3.94	0.00	0.30	0.30	0.30	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	19.54	5.58	0.38	0.13	0.25	0.13	0.13	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	13.95	2.73	0.30	0.00	0.15	0.30	0.15	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.32	6.43	0.40	0.00	0.00	0.13	0.00	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.06	7.33	0.43	0.86	0.43	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	7.32	1.46	0.00	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	32.06	3.00	0.69	0.00	0.00	0.00	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	30.53	5.09	0.68	0.34	0.34	0.17	0.17	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	28.41	5.87	0.70	0.70	0.23	0.23	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	10.85	2.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	23.57	2.30	0.85	0.12	0.36	0.12	0.24	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	13.45	1.58	0.00	0.45	0.23	0.11	0.00	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	14.65	1.92	0.17	0.17	0.00	0.17	0.17	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	14.78	0.81	0.16	0.00	0.16	0.00	0.16	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	31.65	6.04	0.00	0.00	0.21	0.21	0.00	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	41.92	10.48	1.05	0.52	0.26	0.52	0.00	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	21.61	1.71	1.45	0.26	0.13	0.00	0.26	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	32.78	5.61	0.39	0.19	0.10	0.00	0.10	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	35.32	9.35	0.00	0.00	0.00	0.00	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.95	4.93	1.41	0.70	0.35	0.88	1.06	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	31.34	3.43	0.78	0.31	0.16	0.16	0.16	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.21	5.95	0.54	0.54	0.54	0.14	0.00	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	72.69	11.29	0.35	0.00	0.35	0.00	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.66	4.97	0.58	0.15	0.44	0.00	0.73	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.68	4.64	0.95	0.00	0.14	0.14	0.41	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.34	4.72	0.88	0.33	0.33	0.11	0.11	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	41.82	15.26	1.47	0.59	0.59	0.29	0.88	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	12.23	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	23.87	4.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	23.64	2.74	0.21	0.42	0.00	0.21	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	21.66	6.66	0.00	0.83	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	6.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	12.59	2.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	49.12	12.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	18.43	2.91	0.78	0.00	0.19	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.48	1.82	0.61	0.15	0.30	0.46	0.30	0.30	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	33.66	9.18	0.61	0.00	0.00	0.00	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	40.07	6.87	0.38	0.76	0.00	1.14	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	33.75	7.56	1.35	0.00	0.00	0.27	0.54	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	51.26	11.13	0.81	0.23	0.35	0.46	0.23	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.80	2.87	0.33	0.11	0.11	0.00	0.11	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.50	12.39	0.61	0.00	0.00	0.00	0.20	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	2.67	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.21	2.77	0.40	0.00	0.40	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.30	6.35	1.39	0.20	0.20	0.00	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.77	7.99	1.42	0.18	0.53	0.18	0.18	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.93	7.88	1.58	0.59	0.20	0.39	0.59	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.13	12.34	0.30	0.60	0.30	0.60	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.80	10.69	0.65	0.22	0.22	0.32	0.22	0.00	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.72	10.38	1.01	0.00	0.25	0.00	0.76	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	36.43	10.50	1.15	0.00	0.16	0.33	0.00	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.44	9.82	0.60	0.60	0.00	0.20	0.00	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	22.30	8.04	0.80	0.10	0.30	0.10	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	18.13	5.44	0.60	0.00	0.30	0.30	0.60	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.66	7.46	0.17	0.08	0.17	0.25	0.66	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	26.50	11.62	1.54	0.51	0.51	0.17	0.34	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.09	12.48	1.31	0.33	0.00	0.00	0.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.17	6.28	0.64	0.32	0.00	0.00	0.53	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	21.93	4.22	0.84	0.17	0.00	0.00	0.00	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.17	1.88	4.08	0.94	0.78	0.31	2.04	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	37.48	35.73	1.74	0.00	0.87	0.00	1.74	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	44.21	15.43	0.69	0.00	0.35	0.52	0.35	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	47.36	18.22	0.52	0.26	0.00	0.52	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.48	17.89	0.26	0.26	0.26	0.00	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	15.31	0.77	0.77	0.00	0.00	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	11.49	2.55	0.64	0.00	0.00	0.00	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	17.40	0.57	0.57	0.29	0.00	0.00	1.43	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	44.95	1.65	0.83	0.55	0.55	0.83	0.55	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.46	5.25	0.68	0.68	0.46	0.68	0.46	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	27.14	0.99	0.40	0.20	0.40	0.40	1.19	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	31.46	1.06	1.06	0.53	0.26	0.53	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	70.12	8.48	0.98	0.00	0.33	0.98	1.30	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.04	0.88	0.88	0.44	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.28	3.67	1.13	0.42	0.28	0.14	0.57	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	55.04	7.27	1.97	0.74	0.62	0.74	0.86	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.12	4.03	0.27	0.00	0.27	0.27	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	95.89	10.04	3.84	1.73	1.49	0.50	1.61	0.25	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	116.97	11.49	5.40	1.25	0.97	0.69	1.94	0.14	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	89.66	6.91	3.05	0.81	0.81	0.20	1.42	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	70.28	8.21	2.74	1.14	1.14	0.23	1.37	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	85.45	11.96	3.11	1.00	1.37	1.25	1.00	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	126.77	10.27	2.40	0.87	0.66	1.97	1.09	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.07	6.50	1.77	0.89	0.89	0.00	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.87	7.15	3.02	0.95	0.95	0.32	1.27	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	65.24	7.15	2.01	0.22	0.00	0.45	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	36.70	4.03	3.02	0.60	0.00	0.00	0.81	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.98	4.58	1.70	0.17	0.34	0.51	0.85	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	62.25	9.40	1.77	0.44	0.44	0.62	0.53	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.11	4.89	0.42	0.10	0.00	0.52	0.52	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.16	3.76	0.68	0.34	0.00	0.17	0.17	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	34.86	3.32	1.11	0.22	0.11	0.11	0.44	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	44.18	7.82	1.66	0.17	0.25	0.58	0.50	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.04	5.72	1.02	0.20	0.00	0.20	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.17	3.09	1.44	0.41	0.41	0.00	0.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	38.62	4.96	1.15	0.35	0.46	0.35	0.35	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.19	4.17	0.50	0.17	0.00	0.33	0.17	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	42.32	3.53	1.98	0.88	0.22	0.22	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.42	4.43	1.60	0.00	0.49	0.61	0.37	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.95	5.67	1.13	0.16	0.65	0.16	0.49	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	53.24	5.77	1.60	0.64	1.28	0.96	0.64	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.57	5.31	0.85	0.57	0.47	0.76	0.00	0.00	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.81	5.85	0.95	0.47	0.16	0.32	0.32	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	48.96	5.17	1.52	0.91	0.30	0.30	0.91	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	33.24	6.59	1.67	0.42	0.94	0.31	0.21	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.35	5.27	1.10	0.66	0.44	0.88	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	42.08	5.05	1.68	1.12	0.00	0.84	0.28	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.35	7.31	0.65	0.46	0.19	0.65	0.28	0.28	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.41	3.74	0.27	0.00	0.53	0.80	0.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.51	5.51	1.38	0.61	0.61	0.46	0.15	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	28.50	5.44	0.39	0.13	0.39	0.13	0.13	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.99	2.71	0.27	0.27	0.00	0.00	0.27	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.03	4.42	1.84	0.18	0.37	0.18	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	41.23	4.82	0.66	0.22	0.44	0.22	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	4.96	0.99	0.99	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.80	5.14	0.92	0.26	0.79	0.53	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.01	7.87	1.41	0.20	0.81	0.61	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	98.36	7.88	1.02	1.02	0.25	1.52	0.51	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	14.73	2.39	0.80	0.20	0.80	0.00	0.40	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.96	3.54	1.54	0.15	0.15	0.46	0.15	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	20.87	2.45	0.41	0.61	0.20	0.20	0.61	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	35.99	5.32	0.00	0.00	0.31	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	27.69	3.39	0.00	0.28	0.28	0.57	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.50	2.31	2.77	0.92	1.38	0.00	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	2.47	0.00	0.00	7.42	0.00	4.95	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	44.10	6.58	1.93	0.39	0.39	0.00	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	6.42	1.60	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	5.22	0.00	0.00	0.00	1.74	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.57	2.28	0.65	0.00	0.65	1.30	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.88	1.24	0.82	0.41	0.82	0.82	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	3.33	0.00	0.00	0.00	0.00	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.36	3.36	0.56	0.00	0.00	0.84	1.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.42	0.98	1.63	0.33	0.65	0.98	0.33	1.31	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	53.69	1.68	1.68	0.00	0.84	0.00	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.44	2.86	0.95	0.64	0.00	0.00	0.32	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.59	2.38	0.68	0.34	0.34	0.34	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	0.00	0.00	2.09	0.00	0.00	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	41.81	1.72	1.15	1.72	2.86	0.00	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	35.81	1.78	1.18	0.30	1.48	0.59	0.59	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	5.08	0.00	1.69	0.00	0.00	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	35.21	4.56	1.66	1.66	0.83	0.41	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	46.72	4.60	1.38	0.69	0.69	1.15	0.69	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	5.27	0.00	0.00	0.00	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	31.52	4.23	1.92	0.77	0.77	0.77	0.77	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	36.51	4.24	0.98	0.65	0.65	0.33	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.14	3.34	0.67	0.67	1.34	0.67	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	37.37	2.70	0.77	1.54	1.93	1.16	2.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	51.01	5.82	2.74	1.71	2.05	0.34	2.05	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	86.97	4.97	4.97	0.00	4.97	4.97	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	53.32	3.30	3.30	1.42	0.94	1.89	1.42	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	38.02	1.21	1.81	0.60	1.21	0.00	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	64.09	3.56	0.51	0.00	1.53	1.02	1.02	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	49.85	2.39	1.99	0.40	1.20	0.40	3.99	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.35	2.47	2.47	1.48	0.49	0.00	0.99	0.49	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	47.22	3.54	0.00	1.18	1.18	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.01	4.08	0.58	1.17	1.17	0.00	1.75	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.47	4.83	1.32	0.44	1.76	1.32	0.88	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.99	3.39	2.54	1.70	0.85	0.85	3.39	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	45.37	5.37	1.19	0.60	2.39	1.79	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.54	2.91	4.37	1.46	0.97	0.97	1.46	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	25.11	3.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	20.38	3.33	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	3.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.79	5.71	0.95	0.63	0.00	0.00	0.95	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.13	5.43	0.00	0.00	0.42	0.42	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.44	1.04	0.12	0.23	0.00	0.00	0.23	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	6.41	1.18	0.17	0.17	0.00	0.17	0.17	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.78	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	7.65	1.53	0.33	0.00	0.11	0.00	0.33	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	8.17	1.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	7.97	1.72	0.00	0.00	0.00	0.22	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.47	1.00	0.25	0.12	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.72	1.03	0.17	0.17	0.00	0.17	0.00	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.41	1.60	0.00	0.00	0.00	0.00	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.83	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.34	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	7.93	2.64	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.46	2.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	24.70	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	13.29	1.92	0.00	0.00	0.00	0.17	0.17	0.00	0.00
Hepatocyte, donor1	11523-119I2	36.32	7.26	2.42	1.21	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	29.09	5.39	1.08	2.15	0.00	0.00	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	43.56	11.04	1.23	0.61	1.23	0.00	0.61	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	1.31	0.00	0.00	0.00	0.00	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.17	5.24	1.05	0.35	0.35	0.00	0.17	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	31.28	11.11	0.82	0.69	0.14	0.27	0.41	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	6.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	0.00	0.00	0.00	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.11	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	6.43	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.14	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.94	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	31.58	10.53	1.14	0.24	0.16	0.33	0.24	0.24	0.08
Keratinocyte - epidermal, donor2	11349-117G8	11.13	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	29.53	6.72	1.14	0.38	0.76	0.38	0.47	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	37.91	8.40	1.02	0.23	0.57	0.23	0.11	0.00	0.00
Keratocytes, donor1	11527-119I6	41.95	6.88	0.34	0.34	0.34	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	14.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	36.75	6.72	1.58	0.20	0.40	0.20	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	8.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	33.44	4.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	43.25	6.11	0.92	0.58	0.12	0.00	0.58	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	62.16	30.47	0.71	0.40	0.50	0.30	0.20	0.20	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.91	2.13	0.12	0.12	0.12	0.00	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.93	0.28	0.56	0.56	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.90	2.83	0.31	0.16	0.16	0.16	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	2.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.98	2.84	1.89	0.32	0.32	0.00	0.95	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.40	3.13	0.22	0.11	0.11	0.11	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.44	1.23	0.82	0.82	0.41	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.84	1.26	0.51	0.00	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.45	2.82	0.28	0.00	0.42	0.14	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.28	2.77	1.19	0.40	0.40	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.80	2.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.03	1.30	0.00	0.00	0.00	0.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.54	2.09	0.00	0.00	0.00	0.35	0.00	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.87	1.67	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.75	2.61	0.27	0.00	0.14	0.00	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	13.55	2.46	0.31	0.62	0.31	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.04	3.12	0.00	0.31	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.89	2.74	0.18	0.00	0.00	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.82	3.95	0.33	0.00	0.66	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.86	0.88	0.00	0.00	0.00	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.19	2.49	0.00	0.25	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	2.91	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.35	1.35	0.00	0.00	0.00	0.00	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.20	3.33	0.76	0.00	0.00	0.00	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	0.52	0.00	0.00	0.00	0.00	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.89	2.51	0.21	0.63	0.21	0.21	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.92	3.46	0.15	0.00	0.00	0.15	0.30	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.47	1.51	0.38	0.00	0.00	0.00	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.50	2.01	0.21	0.00	0.21	0.00	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	1.94	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.59	2.65	0.66	0.33	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.16	3.22	0.00	0.12	0.00	0.12	0.12	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.48	2.59	0.37	0.74	0.00	0.00	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	9.14	1.73	0.25	0.00	0.00	0.49	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.96	2.06	0.14	0.14	0.27	0.27	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	2.89	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.35	4.56	0.00	0.00	0.00	0.00	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.46	2.24	0.42	0.00	0.00	0.00	0.28	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	3.20	1.07	0.00	0.00	0.00	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.51	3.11	0.00	0.00	0.16	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.47	2.51	0.72	0.36	0.00	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.74	1.96	0.00	0.00	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.83	2.35	0.24	0.24	0.00	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.83	3.84	0.74	0.00	0.12	0.12	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.27	1.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.14	1.49	0.00	0.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	11.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	51.40	13.04	0.77	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	37.11	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	33.00	6.77	0.00	0.42	0.00	0.42	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	56.97	4.92	0.70	0.00	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	42.03	11.21	0.00	0.00	0.00	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	36.58	4.64	1.03	0.52	0.00	1.55	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	39.25	13.08	1.19	0.00	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	46.82	5.43	0.23	0.00	0.00	0.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	37.23	10.47	1.16	0.87	0.58	1.45	1.45	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	54.02	8.10	1.35	0.90	0.90	1.80	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	57.45	12.87	0.27	0.14	0.00	0.81	0.00	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	40.05	7.70	0.00	0.51	0.00	1.03	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	50.11	10.59	0.71	0.71	0.00	0.35	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	46.64	8.00	0.67	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	46.35	12.23	1.53	1.02	0.00	1.02	0.51	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	51.76	12.81	2.40	0.53	0.80	0.00	0.53	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	51.39	8.88	1.32	0.76	0.19	0.38	0.19	0.94	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	47.24	6.75	0.00	0.00	0.00	1.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	66.86	7.34	1.63	0.00	0.82	0.00	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	58.10	9.16	1.87	1.04	0.21	1.67	1.04	0.21	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	51.29	7.85	1.40	1.12	2.24	0.84	0.84	2.24	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	57.70	10.30	0.00	0.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	61.25	10.16	2.61	0.87	1.16	0.58	0.87	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	58.29	13.15	1.79	0.90	0.30	0.90	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	63.07	8.30	2.21	0.55	0.00	1.11	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	54.44	10.96	1.41	0.00	0.71	0.00	1.06	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	52.74	11.06	1.11	0.74	0.37	0.37	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	12.66	0.00	0.00	0.00	1.15	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	44.90	8.83	0.38	0.38	0.38	0.38	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	37.93	13.02	0.57	0.00	0.57	1.70	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	51.69	7.38	0.82	1.64	0.00	1.64	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	50.16	10.85	1.36	1.36	0.00	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	45.24	15.08	0.72	0.00	0.00	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	58.26	11.20	2.24	0.00	0.75	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	46.82	8.92	0.37	0.74	1.11	1.11	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	45.23	9.05	0.86	0.86	0.43	0.86	1.29	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	52.23	8.56	1.71	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	57.97	11.66	1.00	0.33	1.33	1.33	1.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.80	12.07	0.60	0.00	0.60	1.21	2.41	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	46.21	12.09	0.00	0.00	0.71	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	55.34	8.25	1.37	0.69	0.34	2.06	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	42.40	9.12	2.15	0.00	0.54	0.54	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	45.12	12.12	0.67	0.00	0.67	0.67	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	50.01	11.85	2.22	0.37	1.11	1.11	0.37	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	45.35	8.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	48.66	6.35	1.06	0.00	0.00	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	52.42	10.80	1.60	0.00	1.60	0.80	0.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	42.89	5.81	0.00	0.00	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	57.49	11.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	49.33	7.40	0.99	0.00	0.00	1.48	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	13.17	0.00	0.00	0.94	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	55.81	11.56	0.00	0.50	0.00	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	51.82	8.11	0.90	0.00	0.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	0.00	0.00	0.00	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	56.11	15.14	0.45	0.00	0.89	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	56.31	11.73	1.96	0.00	0.39	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	33.65	13.85	0.00	0.00	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	50.34	10.90	1.04	0.00	0.52	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	47.26	9.19	0.88	0.44	1.31	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	50.88	5.03	0.56	0.56	0.00	0.56	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	68.45	12.81	0.44	0.44	0.44	1.32	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.60	10.41	1.16	0.77	0.77	0.00	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	50.13	10.63	0.51	0.51	0.51	0.51	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	65.84	14.42	0.48	0.00	0.48	0.48	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	59.23	10.34	0.00	0.40	0.00	3.18	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	39.50	8.51	1.22	0.00	0.00	1.82	1.22	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	29.05	11.76	1.38	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	66.12	11.78	1.52	0.38	0.76	0.76	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	37.70	5.16	1.03	0.52	1.03	0.00	1.03	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	38.70	10.88	1.81	0.00	0.60	0.00	0.00	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	51.97	7.92	0.63	0.32	0.63	0.00	0.32	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	50.11	13.33	0.00	0.00	0.53	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.61	10.92	0.57	0.57	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	46.80	8.23	0.51	0.00	0.51	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	41.73	6.37	0.00	1.41	0.71	0.71	0.00	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	37.45	14.75	1.13	0.57	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	49.51	8.74	0.83	0.00	0.83	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	38.37	10.96	0.00	0.00	0.78	0.78	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	36.74	10.02	1.25	0.00	0.00	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	59.01	9.29	0.93	0.46	0.46	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.79	10.70	0.67	0.67	0.67	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	49.19	14.97	1.60	0.53	1.07	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	45.26	8.49	0.81	0.81	0.40	0.40	0.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.04	9.18	0.00	0.92	0.00	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	27.56	10.67	0.89	0.00	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	52.43	11.40	1.14	0.00	0.00	2.28	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	38.34	6.90	0.00	0.00	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	35.57	20.25	1.09	0.55	1.09	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	52.12	11.14	0.45	0.00	0.45	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	55.37	12.22	0.00	0.00	0.00	0.52	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	32.49	14.59	0.00	0.00	0.66	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	74.83	16.63	0.00	2.08	0.00	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	53.10	12.99	0.68	0.91	0.46	0.00	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	39.27	11.38	0.00	0.00	0.00	0.37	0.18	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	77.34	13.89	1.70	0.13	0.13	0.39	0.26	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	18.59	6.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	32.01	11.41	0.79	0.48	0.00	0.32	0.32	0.48	0.00
Mallassez-derived cells, donor3	11930-125I4	26.69	9.87	0.97	0.14	0.14	0.14	0.28	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	26.90	10.46	1.20	0.20	0.40	0.10	0.00	0.20	0.00
Mammary Epithelial Cell, donor2	11350-117G9	20.56	5.50	0.58	0.00	0.29	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	29.93	7.73	0.25	0.25	0.75	0.25	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	215.58	42.71	0.00	0.00	0.68	4.75	0.00	1.36	0.68
Mast cell, donor1	11563-120D6	129.66	24.76	3.46	0.97	0.87	1.41	0.65	0.43	0.11
Mast cell, donor2	11565-120D8	323.62	28.53	6.24	1.49	1.49	5.94	2.38	1.19	0.89
Mast cell, donor3	11566-120D9	329.13	31.52	1.58	1.80	0.45	4.28	0.23	0.45	0.45
Mast cell, donor4	11567-120E1	346.60	44.14	1.24	1.06	0.71	5.14	0.89	0.89	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	128.64	20.40	4.66	1.11	1.00	1.33	0.89	0.67	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	109.15	19.26	5.25	2.92	1.17	4.09	1.75	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	101.87	18.36	1.49	1.03	1.49	1.95	1.26	0.57	0.23
Mast cell, expanded, donor8	11941-126A6	212.39	51.05	4.35	1.17	2.34	5.69	2.34	0.67	0.33
Melanocyte - dark, donor1	11502-119F8	14.03	2.09	0.40	0.00	0.00	0.00	0.20	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	11.42	0.69	0.00	0.00	0.00	0.35	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	26.88	2.90	0.80	0.00	0.14	0.14	0.14	0.00	0.00
Melanocyte - light, donor1	11274-116H5	23.98	8.23	0.00	0.24	0.47	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	17.06	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.08	2.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	13.43	1.56	0.31	0.10	0.10	0.10	0.00	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	15.60	1.61	0.00	0.27	0.27	0.00	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	27.59	0.54	0.27	0.00	0.27	0.00	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	26.80	4.47	0.37	0.12	0.00	0.12	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	21.13	5.28	0.88	0.00	0.44	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	28.44	4.32	0.57	0.16	0.16	0.16	0.08	0.08	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	23.10	1.71	0.29	0.29	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	69.84	23.85	0.70	0.20	0.20	0.30	0.30	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	4.31	0.72	0.72	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	41.08	7.62	1.27	0.00	0.00	0.21	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.13	6.53	1.01	0.50	0.00	1.01	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.66	2.42	0.44	0.00	0.22	0.00	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	2.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	21.89	3.68	0.20	0.00	0.20	0.41	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.65	6.51	0.69	0.00	0.42	0.28	0.14	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.29	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.05	2.37	0.92	0.13	0.26	0.13	0.39	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.61	2.08	0.00	0.00	0.30	0.30	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	3.84	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.20	4.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.76	2.50	0.94	0.31	0.31	0.31	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	16.69	3.63	0.00	0.00	0.00	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	45.08	21.21	0.80	0.27	0.80	0.27	0.27	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	38.04	17.52	0.50	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	39.10	9.11	0.87	0.22	0.00	0.29	0.36	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	27.01	9.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	48.76	11.82	1.48	1.72	0.00	0.25	0.99	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	52.12	12.66	1.18	0.29	0.59	1.47	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	38.12	10.23	0.93	0.31	0.00	0.62	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	37.55	8.50	0.62	0.21	0.21	0.21	0.62	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	53.56	12.26	0.25	1.25	0.25	0.75	1.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.89	11.64	0.93	0.00	0.00	0.47	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	47.76	8.74	1.63	0.41	0.20	0.20	1.02	0.00	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	49.10	12.67	0.79	0.00	0.40	0.79	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	22.12	6.19	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.51	7.98	2.28	0.00	0.38	0.00	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	26.95	8.49	0.64	0.64	0.64	0.42	0.64	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	21.18	6.45	0.92	1.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	31.30	10.13	0.60	0.00	0.30	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	30.61	8.28	1.51	0.50	0.50	0.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.62	7.37	0.24	0.00	0.24	0.48	0.48	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.93	5.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	38.68	7.14	1.61	0.00	0.00	0.92	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	34.92	9.47	0.42	0.42	0.42	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	38.12	9.17	0.61	0.61	0.41	0.00	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	36.04	5.58	0.64	0.00	0.21	0.43	1.07	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	32.23	8.45	0.89	0.22	0.67	0.22	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	33.07	8.98	0.88	0.22	0.00	0.22	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.84	7.10	1.01	0.00	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	8.28	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.25	5.71	0.82	0.82	0.27	0.00	1.09	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	28.53	8.82	0.59	0.59	0.29	0.00	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.22	4.81	0.48	0.00	0.00	0.00	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	25.61	7.20	1.60	0.00	0.40	0.40	0.00	1.20	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	34.54	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	22.42	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	25.84	5.26	0.88	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	4.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.33	3.20	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	30.00	6.45	0.25	0.25	0.25	0.00	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	21.57	5.57	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	40.68	11.28	0.34	0.34	0.00	0.00	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.32	7.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	24.86	6.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	41.24	8.98	1.96	0.56	0.00	0.00	0.56	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	5.82	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	40.21	8.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	43.14	9.65	1.51	0.30	1.21	0.30	0.60	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	31.72	10.85	0.42	0.00	0.00	1.25	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	42.48	5.54	1.85	1.85	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	46.10	13.09	0.00	0.57	0.00	0.00	0.57	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	40.90	17.83	1.11	0.83	0.00	0.28	0.28	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	45.87	13.48	1.30	0.00	0.26	0.78	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	42.04	18.02	0.43	0.43	0.00	0.00	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	38.11	11.43	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	42.44	16.55	0.80	1.07	0.80	0.53	0.00	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	67.05	30.53	2.39	0.90	0.30	1.50	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	50.57	21.05	1.13	1.13	0.14	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	39.18	16.88	1.27	0.32	0.32	1.27	0.64	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	49.75	23.00	0.66	0.22	0.44	0.66	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	42.85	15.17	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	40.63	21.31	1.14	0.28	0.00	0.57	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	45.72	22.37	0.98	0.25	0.25	0.74	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	61.91	14.99	0.00	0.00	0.00	0.00	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	61.45	20.88	0.59	0.00	0.29	1.47	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	70.06	23.64	1.15	0.29	0.29	1.44	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	51.52	35.03	0.41	0.82	1.24	1.24	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	55.98	24.42	0.60	0.30	0.60	0.60	0.30	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	55.25	17.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	69.99	18.73	0.99	0.66	1.64	0.33	0.99	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	53.65	8.42	0.00	0.00	2.10	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	58.52	20.56	0.20	0.00	0.79	0.79	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	100.58	29.80	0.00	0.00	0.93	0.00	0.00	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	64.59	13.52	0.75	0.00	1.50	1.13	0.75	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	46.34	15.18	1.07	1.07	0.00	0.80	0.80	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	38.57	11.42	0.23	0.57	0.34	0.11	0.23	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	44.94	10.31	1.47	0.00	0.74	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	67.42	12.82	1.10	0.37	0.37	0.73	1.10	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	24.89	6.22	1.56	4.67	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	38.48	13.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	15.46	0.00	3.86	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	71.71	13.13	0.00	0.00	1.01	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	58.61	14.76	0.42	0.84	0.00	0.84	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	55.84	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	22.25	5.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	36.44	8.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	77.03	10.57	0.00	0.00	0.00	0.00	0.00	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	84.82	0.00	0.00	0.00	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	14.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	46.75	17.88	0.43	0.00	1.08	0.00	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	64.80	14.63	6.27	1.57	0.00	0.52	0.52	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	104.80	4.67	0.67	0.00	2.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	94.33	7.93	1.25	0.00	2.09	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	20.73	2.09	1.90	1.14	0.95	0.19	0.00	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	63.83	17.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	97.23	8.16	0.68	0.00	0.68	0.68	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	9.19	0.00	0.00	0.00	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	89.15	13.39	0.84	0.00	0.84	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	59.74	5.81	0.93	0.23	0.46	0.46	0.46	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	77.56	10.00	0.54	0.27	0.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.00	6.94	0.63	0.21	0.00	0.21	0.21	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	11.13	0.00	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	58.57	6.95	0.99	0.50	0.50	1.49	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	27.61	4.06	1.35	0.81	1.08	0.54	1.62	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	60.75	8.61	0.23	0.00	0.91	0.45	0.23	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	53.07	8.65	0.16	0.16	0.65	0.49	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.37	9.11	0.18	0.18	0.55	0.00	0.18	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	73.73	13.79	0.00	0.53	1.59	0.53	1.06	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	108.66	20.41	1.80	0.60	1.20	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	15.75	2.63	6.56	1.64	0.98	0.98	3.28	0.98	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	73.02	11.38	0.33	0.49	0.33	0.16	0.16	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	49.92	13.23	1.23	0.18	0.71	0.53	0.18	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	89.31	10.55	1.41	0.70	0.70	0.70	0.70	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	98.38	17.47	0.92	1.38	1.84	0.00	0.46	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	69.09	14.46	0.32	0.32	0.32	0.64	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.42	3.45	6.90	2.76	2.07	1.03	5.52	0.69	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	2.53	2.53	2.53	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	40.55	13.59	0.67	0.00	0.00	0.00	0.00	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	72.82	12.28	1.69	0.00	2.12	0.85	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	46.52	5.46	1.66	0.95	1.42	0.47	1.42	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	100.87	10.73	0.86	0.00	0.43	0.43	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	86.97	13.66	0.67	0.33	2.00	1.00	0.33	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	41.93	15.78	0.45	1.80	1.35	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	55.95	12.30	1.19	0.00	0.40	0.79	1.19	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	110.51	28.79	0.00	0.00	0.93	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	54.11	5.68	0.38	0.76	1.89	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	102.00	12.06	0.65	1.30	1.63	0.33	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	82.36	11.33	0.44	0.44	2.61	0.00	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	53.82	10.40	0.00	0.90	0.90	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	100.54	13.23	0.00	0.00	1.76	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	99.06	12.63	1.99	0.00	1.33	0.66	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	90.78	20.83	0.50	0.00	2.98	1.98	0.50	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	127.86	17.99	0.77	0.38	1.91	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	31.15	2.72	0.60	0.30	0.00	0.91	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	42.88	12.16	0.66	0.22	0.00	0.00	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	86.06	11.52	0.00	0.00	1.36	2.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	20.44	5.11	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	85.97	15.24	1.83	0.00	0.61	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	108.27	18.88	1.89	0.63	3.15	0.94	0.00	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	100.78	9.38	1.21	0.30	1.21	0.61	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	84.65	16.61	3.16	0.00	0.79	1.58	1.58	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	3.40	14.74	2.27	2.27	1.13	7.94	0.00	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00	0.00	5.06	0.00	5.06
Myoblast, donor1	11241-116D8	25.47	9.44	0.62	0.00	0.25	0.00	0.37	0.37	0.12
Myoblast, donor2	11322-117D8	26.66	5.75	0.38	0.58	0.19	0.19	0.58	0.38	0.00
Myoblast, donor3	11398-118D3	21.69	4.88	0.50	0.00	0.00	0.00	0.34	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	104.93	18.83	3.06	0.58	0.88	0.88	0.58	0.29	0.15
Natural Killer Cells, donor1	11230-116C6	278.00	168.52	4.92	0.62	1.85	5.84	1.54	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	326.28	150.78	7.24	2.11	2.71	16.59	3.92	0.90	1.51
Natural Killer Cells, donor3	11387-118C1	324.86	128.10	6.26	3.87	1.47	8.47	2.39	0.55	1.10
Neural stem cells, donor1	11275-116H6	162.60	35.57	2.54	2.90	0.36	3.27	3.63	1.09	0.73
Neural stem cells, donor2	11352-117H2	285.00	32.74	3.85	0.00	0.00	0.00	1.93	1.93	0.00
Neurons, donor1	11494-119E9	122.89	13.65	10.24	3.41	3.41	0.00	2.28	1.14	2.28
Neurons, donor2	11574-120E8	132.10	14.09	3.74	1.32	0.88	0.88	2.42	0.44	0.44
Neurons, donor3	11655-122E8	124.97	9.87	0.82	2.47	2.47	0.00	6.58	0.82	0.00
Neutrophils, donor1	11233-116C9	502.05	152.19	38.05	15.78	11.14	12.99	14.85	4.64	7.42
Neutrophils, donor2	11314-117C9	350.76	113.06	86.97	37.69	46.38	8.70	43.48	14.49	11.60
Neutrophils, donor3	11390-118C4	621.23	213.18	13.44	6.11	4.28	15.27	4.89	1.83	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	35.74	5.82	0.47	0.24	0.36	0.00	0.24	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	21.49	3.58	0.33	0.33	0.33	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	22.66	4.01	0.40	0.40	0.40	0.00	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	51.62	12.94	2.06	0.83	0.00	0.69	0.83	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	41.11	8.54	2.03	0.87	0.87	0.58	1.30	0.43	0.29
Olfactory epithelial cells, donor3	11935-125I9	32.92	6.70	1.25	0.11	0.91	0.23	0.68	0.00	0.45
Olfactory epithelial cells, donor4	11936-126A1	55.13	12.56	1.46	0.58	0.97	0.29	0.19	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	35.51	9.63	3.61	0.00	0.00	0.60	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	36.16	10.63	0.21	0.00	0.00	0.21	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	46.87	8.00	0.00	0.00	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	29.17	6.21	2.48	0.00	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	32.64	5.47	0.20	0.00	0.00	0.39	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	40.03	8.43	0.70	0.00	1.40	0.00	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	49.94	8.18	0.18	0.36	0.36	0.18	0.18	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	35.13	7.50	0.93	0.17	0.59	0.17	0.34	0.00	0.17
Pericytes, donor1	11491-119E6	16.24	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	16.52	5.43	0.45	0.68	0.23	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	24.41	5.29	0.41	0.20	0.20	0.20	0.41	0.20	0.20
Perineurial Cells, donor1	11499-119F5	28.59	5.99	1.02	0.23	0.11	0.00	0.45	0.00	0.00
Perineurial Cells, donor2	11579-120F4	14.35	2.48	0.28	0.00	0.09	0.18	0.18	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	131.96	49.72	1.91	0.32	0.00	0.32	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	121.70	45.30	2.45	1.47	0.98	2.20	1.22	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	159.57	42.58	2.20	1.29	0.52	1.94	0.52	0.39	0.39
Placental Epithelial Cells, donor1	11278-116H9	11.00	2.87	0.00	0.00	0.00	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	1.11	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	10.41	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	53.80	10.44	2.22	1.58	2.85	1.27	3.16	0.95	0.63
Preadipocyte - breast, donor1	11467-119B9	28.51	8.63	0.94	0.75	0.38	0.75	0.94	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.88	7.70	0.65	0.00	0.00	0.00	0.39	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	34.22	3.15	0.23	0.90	0.23	0.23	0.68	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	37.19	10.98	0.85	0.11	0.43	0.75	0.53	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	42.34	8.73	1.31	0.00	0.44	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	51.86	9.60	1.86	0.29	0.29	0.86	0.72	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	22.64	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	40.54	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	32.76	3.01	0.89	0.89	0.35	0.35	0.71	0.00	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	49.89	5.79	1.87	0.68	0.51	0.00	0.68	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	34.46	4.66	0.93	0.47	0.19	0.09	0.19	0.37	0.19
Preadipocyte - visceral, donor2	11357-117H7	33.13	7.82	3.68	0.46	1.38	0.46	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	23.61	3.45	0.94	0.21	0.10	0.42	0.10	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	13.43	3.62	1.06	0.00	0.30	0.15	0.15	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	40.89	15.30	2.44	0.54	0.27	0.68	0.95	0.81	0.27
Prostate Epithelial Cells, donor3	11404-118D9	32.03	7.16	1.53	0.43	0.24	0.49	0.55	0.06	0.00
Prostate Stromal Cells, donor1	11254-116F3	29.04	7.06	0.46	0.23	0.11	0.46	0.00	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	30.48	6.45	3.05	0.72	0.54	0.72	1.26	0.18	0.36
Prostate Stromal Cells, donor3	11405-118E1	37.75	7.30	1.67	0.10	0.63	0.42	0.52	0.21	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.39	5.11	0.36	0.00	0.00	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	38.61	6.93	1.18	0.21	0.42	0.21	0.35	0.00	0.28
Renal Epithelial Cells, donor1	11517-119H5	21.81	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	25.61	7.11	0.00	0.00	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	31.87	7.20	0.74	0.11	0.53	0.21	0.32	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	18.19	3.91	0.13	0.00	0.13	0.13	0.27	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	27.53	2.00	2.44	0.00	0.89	0.22	0.67	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	24.43	3.52	0.22	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	23.20	2.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	18.03	2.22	0.28	0.00	0.00	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	33.55	8.05	0.00	0.00	0.27	0.27	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.52	3.37	0.00	0.00	0.42	0.00	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	22.76	4.44	0.39	0.19	0.00	0.19	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	26.19	2.85	0.78	0.00	0.26	0.26	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.99	6.82	0.28	0.00	0.57	0.00	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	21.61	1.03	0.00	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	25.59	6.27	1.00	0.50	0.25	0.00	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	52.65	23.25	1.07	0.27	0.40	0.94	0.27	0.13	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.95	15.19	5.36	2.68	0.00	0.89	0.89	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.96	7.71	3.30	0.55	1.65	0.55	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	31.90	6.96	0.58	1.16	0.00	0.58	0.58	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	17.55	11.05	0.78	0.13	0.13	0.00	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	33.96	9.63	0.89	0.60	0.00	0.00	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	26.88	7.58	0.33	0.11	0.22	0.00	0.00	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	16.99	8.43	0.99	0.74	0.12	0.37	0.74	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	29.14	9.32	1.28	0.35	0.35	0.47	0.35	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	25.66	6.01	2.77	0.00	0.69	0.69	0.23	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	23.55	8.76	0.68	0.41	0.41	0.00	0.68	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.50	6.20	0.30	0.00	0.00	0.61	0.30	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	29.39	9.86	0.36	0.18	0.18	0.18	0.36	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.81	11.33	1.15	0.29	0.14	0.00	0.43	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	26.18	6.98	0.64	0.21	0.11	0.11	0.75	0.21	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	22.57	7.97	0.44	0.00	0.00	0.00	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	20.84	8.79	0.96	0.38	0.00	0.19	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	33.63	7.08	0.93	0.37	0.28	0.19	0.28	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.19	9.21	0.00	0.56	0.19	0.19	0.19	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	25.61	9.55	0.66	0.40	0.13	0.13	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	33.00	8.08	0.78	0.19	0.19	0.10	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.07	10.69	2.48	0.76	1.72	0.19	0.57	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	24.46	10.68	1.17	0.21	0.32	0.21	0.00	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	36.16	7.01	1.12	0.56	0.28	0.84	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	25.29	8.37	0.34	0.17	0.68	0.51	0.51	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.34	10.21	0.73	0.73	0.18	0.00	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.87	8.09	1.59	0.37	0.25	0.12	0.86	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	28.07	8.33	0.54	0.40	0.54	0.13	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.58	11.32	1.18	0.24	0.47	0.00	0.71	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	29.96	6.75	0.40	0.20	0.00	0.00	0.20	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.53	9.82	0.23	0.23	0.23	0.23	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	24.68	14.31	1.04	0.00	0.21	0.21	0.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.78	8.18	1.11	0.44	0.22	0.44	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	28.83	6.27	0.42	0.84	0.00	0.00	0.63	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.40	14.27	1.48	0.67	0.27	0.00	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	30.99	8.51	0.85	0.17	0.17	0.17	0.68	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	39.72	7.52	0.96	0.39	0.96	0.19	0.58	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.49	9.46	1.20	0.17	0.17	0.00	0.69	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	35.25	10.01	1.23	1.10	0.27	0.00	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	34.97	8.70	0.66	0.00	0.00	0.49	0.00	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.44	11.25	0.85	0.68	0.17	0.00	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.88	7.69	1.63	0.15	0.44	0.30	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	38.38	11.99	0.27	0.00	0.27	0.00	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	22.68	8.71	1.38	0.14	0.14	0.00	0.28	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.62	6.43	0.71	0.00	0.48	0.00	0.24	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.32	10.08	0.60	0.81	0.60	0.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.46	8.48	1.32	0.28	0.47	0.09	0.66	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.95	11.53	2.45	1.05	0.00	0.35	1.05	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	31.43	10.58	0.60	0.00	0.30	0.30	0.00	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.25	11.26	1.47	0.37	0.24	0.24	0.73	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	55.75	18.49	1.46	1.02	0.44	0.15	0.87	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	33.46	6.08	0.61	0.00	0.61	0.00	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.39	11.15	0.00	0.00	0.60	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	34.38	9.95	2.94	0.90	0.45	0.90	0.90	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.13	11.38	2.70	0.60	0.60	0.60	1.80	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.55	13.11	1.06	0.12	0.24	0.94	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	35.65	14.51	0.85	0.00	0.21	2.77	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.89	12.62	0.00	1.20	0.60	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	15.42	0.94	0.19	0.00	0.00	0.19	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	10.21	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.03	3.51	0.44	0.44	0.00	0.22	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	21.91	7.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	17.92	5.06	0.00	0.00	0.00	0.92	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	29.27	3.50	0.41	0.41	0.21	0.41	0.21	0.41	0.00
Sertoli Cells, donor1	11255-116F4	39.76	11.60	1.66	1.66	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	39.54	11.30	11.30	0.00	0.00	0.00	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	35.19	4.93	0.79	0.26	0.26	0.62	0.26	0.09	0.18
Skeletal Muscle Cells, donor2	11358-117H8	26.02	5.78	0.00	0.72	0.00	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	26.75	5.02	0.00	0.00	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	14.61	3.93	0.63	0.31	0.00	0.16	0.00	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	15.01	3.12	0.15	0.00	0.15	0.15	0.45	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	13.39	2.92	0.31	0.15	0.00	0.31	0.31	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.30	2.90	0.63	0.38	0.25	0.50	0.38	0.00	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	19.69	2.28	0.86	0.57	0.14	0.43	0.14	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	28.77	2.98	0.30	0.30	0.10	0.00	0.60	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.35	8.59	0.84	0.51	0.25	0.51	0.34	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	25.33	3.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	34.40	5.78	0.28	0.14	0.14	0.00	0.14	0.14	0.00
Skin - palm, donor1	10286-104F7	59.09	32.23	8.06	8.06	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.44	11.24	1.01	0.86	0.29	0.43	1.15	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.98	13.09	2.45	0.00	0.00	0.00	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	45.83	13.24	1.95	0.65	0.78	0.91	0.26	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	18.91	12.23	1.53	0.00	0.56	0.42	0.42	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	29.26	8.86	0.84	0.14	0.28	0.28	0.28	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	51.17	22.84	2.33	0.63	0.00	0.42	0.42	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	45.49	13.87	0.82	0.60	0.30	0.07	0.52	0.22	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	31.78	5.55	1.54	0.93	0.62	0.62	1.23	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.45	26.46	0.89	0.22	0.22	0.00	0.67	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	62.31	10.58	1.18	0.00	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.04	7.96	0.22	0.00	0.44	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	36.62	9.45	0.00	0.39	0.39	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	48.67	6.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	71.73	19.96	0.13	0.13	0.27	0.27	0.00	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	46.10	16.85	2.22	0.66	0.44	0.44	0.89	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.65	6.53	0.00	0.13	0.00	0.26	0.26	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.81	2.60	0.33	0.00	0.00	0.00	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.69	6.79	0.00	0.00	0.00	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	21.78	4.98	0.28	0.00	0.14	0.43	0.14	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.20	0.65	0.16	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	13.70	1.22	0.91	0.00	0.61	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	32.83	9.85	0.51	0.00	0.00	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	41.48	12.87	0.00	0.00	0.48	0.95	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	13.86	2.95	0.74	0.00	0.29	0.00	0.15	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.99	2.37	0.65	0.22	0.00	0.65	0.22	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.79	3.78	0.10	0.21	0.10	0.00	0.42	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	44.70	9.59	0.00	0.00	0.00	0.31	0.15	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	40.96	5.39	0.00	0.00	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	30.48	9.86	0.30	0.00	0.00	1.20	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.05	2.05	0.00	0.34	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.73	3.38	0.55	0.08	0.55	0.00	0.00	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	76.99	23.65	2.72	1.21	0.60	1.21	2.21	1.01	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	61.89	23.67	2.05	0.00	0.91	0.68	0.68	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	32.00	10.26	0.00	0.00	0.00	0.60	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.01	1.32	0.26	0.00	0.00	0.00	0.26	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.23	10.25	0.80	0.80	0.40	0.27	0.80	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	38.19	10.39	1.88	0.88	0.38	0.50	0.75	0.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	32.72	8.12	0.51	0.00	0.00	0.51	0.51	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	48.25	6.48	0.00	0.00	0.15	0.45	0.15	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	36.01	4.50	0.75	0.00	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	5.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	39.53	9.77	0.00	0.00	0.00	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	56.55	17.17	2.02	1.01	1.01	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	45.44	16.30	0.94	0.31	0.31	1.25	1.25	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.17	2.95	0.00	0.00	0.29	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.74	3.33	0.17	0.08	0.08	0.00	0.17	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.63	1.40	0.93	0.47	0.00	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	60.30	17.99	0.72	0.14	0.00	0.43	0.14	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	47.42	9.18	1.02	0.25	0.25	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	31.03	4.89	0.38	0.19	0.19	0.19	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	24.60	4.61	0.56	0.42	0.14	0.00	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.15	8.63	0.17	0.08	0.08	0.08	0.00	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.10	1.43	0.00	0.00	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	61.17	12.97	0.24	0.00	0.00	0.73	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.86	14.14	0.88	0.44	0.00	0.66	0.44	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.65	2.63	0.00	0.00	0.29	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	25.46	4.47	0.78	0.39	0.19	0.19	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.89	6.35	1.06	0.26	0.79	0.26	0.53	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	15.25	4.84	1.49	0.37	1.12	1.49	0.00	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	42.76	14.01	1.08	0.72	0.36	0.00	1.08	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	40.03	9.08	1.14	0.57	0.85	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.88	4.33	0.79	0.00	0.39	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	18.28	4.32	1.78	0.76	0.51	0.25	1.27	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	30.75	8.39	0.40	0.40	1.20	0.40	1.20	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	23.83	4.60	1.25	1.25	0.42	0.84	0.84	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	28.42	6.42	0.46	0.46	0.46	0.46	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	51.34	11.45	1.68	0.50	0.50	0.00	0.67	0.17	0.00
Synoviocyte, donor2	11368-117I9	83.48	26.99	5.53	1.17	1.34	1.34	2.35	0.84	0.50
Synoviocyte, donor3	11440-118H9	68.59	36.86	9.83	1.34	0.67	0.45	9.61	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	27.87	0.36	0.00	0.36	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	1.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	20.38	1.85	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	15.27	4.44	0.00	0.00	0.07	0.14	0.00	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	17.01	1.55	0.77	0.00	0.00	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	56.10	24.24	0.62	0.12	0.25	0.25	0.12	0.12	0.25
Urethra, donor2	10319-105A4	102.51	10.79	21.58	5.40	3.60	0.00	3.60	0.00	1.80
Urothelial Cells, donor1	11520-119H8	20.72	7.17	0.00	0.27	0.27	0.27	0.27	0.53	0.27
Urothelial Cells, donor2	11600-120H7	13.22	5.21	0.00	0.00	1.20	0.40	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	18.11	5.27	0.23	0.00	0.00	0.23	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	33.21	9.14	0.89	0.67	0.45	0.00	0.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	150.37	69.40	0.00	0.00	0.00	1.78	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	187.28	94.35	2.86	2.86	4.29	2.86	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	176.61	41.07	4.79	2.74	4.11	1.37	2.05	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	160.12	47.52	3.10	1.03	1.38	0.69	0.69	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	123.18	39.51	2.32	1.16	0.00	1.16	2.91	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	145.77	70.80	1.04	4.16	2.08	2.08	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	119.31	62.41	6.42	3.67	1.84	3.67	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	169.80	41.08	9.13	0.00	0.91	1.83	1.83	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	31.70	1.85	0.74	0.37	0.12	0.12	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	32.56	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	26.54	6.98	0.28	0.28	0.28	0.00	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	86.79	22.73	6.20	4.13	4.13	0.00	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.60	3.57	3.82	0.76	1.27	0.76	1.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.23	0.93	0.70	0.23	0.00	0.00	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	25.05	2.49	0.47	0.12	0.12	0.24	0.24	0.00	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	39.46	2.99	0.82	0.82	1.09	0.00	0.00	0.54	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	40.19	6.75	3.09	0.56	0.00	0.00	0.00	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	51.39	12.48	0.85	0.42	0.21	0.21	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	71.59	10.07	2.45	1.09	0.82	1.36	1.36	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.51	0.88	0.44	0.00	0.00	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	51.86	19.19	4.08	2.04	0.00	0.00	1.23	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	109.89	12.43	0.78	0.39	1.16	1.94	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.91	3.50	0.00	0.00	0.00	0.00	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	11.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	36.95	6.27	0.46	0.23	1.16	0.23	0.70	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	14.50	1.81	0.52	0.26	0.00	0.00	0.52	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.64	1.75	0.29	0.29	0.00	0.29	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	14.41	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	45.65	30.84	1.23	0.41	0.41	0.00	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	32.23	10.13	0.31	0.31	0.00	0.00	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	17.50	7.25	0.43	0.43	0.00	0.00	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.41	6.98	0.30	0.30	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.53	13.48	0.48	0.24	0.24	0.00	0.48	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.92	4.68	0.45	0.22	0.00	0.22	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	46.36	6.34	0.00	0.00	0.67	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.10	3.93	1.74	0.00	0.87	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	5.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	30.14	4.47	0.00	0.00	0.24	0.24	0.00	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	48.40	12.56	0.31	0.47	1.09	0.47	0.31	0.31	0.00
adipose, donor1	10184-103D4	14.07	0.00	5.28	0.59	0.00	1.17	1.17	0.00	0.00
adipose, donor2	10185-103D5	82.73	5.68	1.62	0.41	1.62	1.62	2.43	0.00	0.00
adipose, donor3	10186-103D6	50.37	6.26	0.54	0.54	0.54	1.09	2.18	0.00	0.54
adipose, donor4	10187-103D7	25.14	2.60	0.00	0.00	0.00	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	60.60	1.26	0.63	0.00	0.47	0.00	0.16	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	80.03	10.91	0.00	0.00	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	52.43	5.74	1.20	0.13	0.27	0.27	0.40	0.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	76.10	15.01	1.79	1.07	1.07	1.07	2.14	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	109.43	63.29	1.16	0.23	1.16	0.46	0.93	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	29.75	14.20	0.00	0.00	0.34	0.68	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	50.38	45.66	3.83	0.59	0.88	0.59	1.77	0.00	0.00
amygdala - adult, donor10196	10167-103B5	1000.81	169.57	48.62	13.04	22.53	5.93	13.04	1.19	3.56
amygdala, adult, donor10252	10151-102I7	1075.68	70.77	60.02	54.54	18.86	9.53	6.69	4.87	11.96
amygdala, newborn, donor10223	10360-105E9	429.93	50.35	30.02	12.27	3.23	4.84	13.23	0.32	4.52
anaplastic carcinoma cell line:8305C	10428-106D5	75.12	15.02	2.42	0.51	1.15	0.64	0.64	0.51	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	88.25	15.66	1.54	1.32	1.10	0.66	0.00	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	82.84	3.34	1.00	1.00	1.00	0.67	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	175.74	26.28	3.33	1.57	2.35	1.57	0.59	0.78	0.59
appendix, adult	10189-103D9	97.42	13.97	0.78	0.39	0.78	0.78	0.00	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	52.97	6.88	1.38	0.69	0.00	0.34	1.03	0.00	0.00
artery, adult	10190-103E1	78.80	10.87	4.08	0.00	4.08	1.36	1.36	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	92.14	17.24	3.33	0.87	1.16	0.58	1.16	0.87	0.43
b cell line:RPMI1788	10427-106D4	77.92	5.06	1.19	0.30	0.89	0.45	0.45	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	70.19	23.31	0.83	1.11	0.28	1.94	0.83	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	92.48	18.66	1.39	0.40	0.60	0.20	0.40	0.50	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	19.25	4.18	0.17	0.33	0.00	0.00	0.17	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.63	4.47	0.56	0.56	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	76.92	15.21	1.41	0.87	0.76	0.43	0.22	0.11	0.11
blood, adult, pool1	10053-101G8	128.45	28.79	8.86	0.00	2.21	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	59.09	29.12	0.00	0.00	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	51.96	8.10	5.40	4.72	0.67	0.00	3.37	0.00	0.67
brain, adult, donor1	10084-102B3	736.00	93.28	2.05	3.08	14.35	6.15	5.13	1.03	1.03
brain, adult, pool1	10012-101C3	673.05	113.92	21.27	9.80	8.02	5.90	4.79	3.34	2.56
brain, fetal, pool1	10085-102B4	379.34	26.71	0.00	2.67	5.34	2.67	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	34.69	3.63	1.32	1.32	0.99	0.99	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	79.51	12.36	1.62	0.37	0.12	0.37	0.25	0.00	0.12
breast, adult, donor1	10080-102A8	75.13	13.26	0.00	0.00	0.00	1.26	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.60	9.02	1.52	0.64	0.25	0.13	0.76	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	185.84	26.59	6.49	0.93	0.93	2.47	3.09	0.93	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.05	9.90	5.76	1.84	2.30	0.46	1.15	1.15	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	30.02	7.99	0.24	0.48	0.00	0.24	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	26.80	0.94	0.00	0.00	0.47	0.47	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	111.46	18.27	1.97	0.66	0.77	0.33	0.33	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	31.06	2.54	0.00	0.32	0.32	0.00	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.86	6.12	2.40	0.27	0.27	0.00	1.06	0.00	1.06
caudate nucleus - adult, donor10196	10177-103C6	786.35	92.11	23.03	12.66	9.21	8.06	2.30	1.15	5.76
caudate nucleus, adult, donor10252	10164-103B2	858.22	63.25	34.13	38.32	11.04	8.37	6.86	4.02	3.51
caudate nucleus, adult, donor10258	10379-105H1	1108.77	83.29	30.57	18.34	9.93	3.06	10.70	1.53	3.06
caudate nucleus, newborn, donor10223	10354-105E3	362.94	36.62	13.18	5.49	2.20	5.13	4.03	2.56	1.46
cerebellum - adult, donor10196	10173-103C2	451.56	78.66	8.74	5.83	2.91	2.91	0.00	2.91	11.65
cerebellum, adult, donor10252	10166-103B4	344.39	61.28	12.81	11.96	2.56	3.63	3.20	2.35	0.64
cerebellum, adult, pool1	10083-102B2	242.15	43.46	12.76	4.14	3.10	1.72	7.93	1.03	1.03
cerebellum, newborn, donor10223	10357-105E6	132.85	21.59	9.13	10.79	0.83	1.66	0.83	0.00	1.66
cerebral meninges, adult	10188-103D8	808.86	65.81	16.89	16.39	7.56	8.32	7.31	4.54	3.53
cerebrospinal fluid, donor2	10294-104G6	122.06	10.96	4.39	3.65	1.46	0.73	3.65	1.46	1.46
cervical cancer cell line:D98-AH2	10552-107I3	12.51	4.17	0.58	0.00	0.14	0.00	0.14	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	36.46	15.74	1.33	0.00	0.33	0.00	0.50	0.17	0.33
cervix, adult, pool1	10013-101C4	92.71	17.32	2.31	0.42	0.94	0.63	0.73	0.10	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	42.36	32.88	2.51	0.28	0.56	0.28	0.98	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	65.31	14.37	1.31	0.00	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	11.06	4.23	0.62	0.00	0.37	0.00	0.25	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	11.09	1.72	0.12	0.00	0.25	0.00	0.25	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	19.69	8.78	0.24	0.24	0.00	0.24	0.47	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	46.16	35.05	1.42	0.00	0.57	0.57	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	44.55	14.52	0.70	0.30	0.10	1.19	0.00	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	27.47	21.98	2.20	1.10	3.30	1.10	2.20	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	64.16	17.87	0.77	0.19	0.38	0.19	0.96	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.23	2.53	0.42	0.42	0.00	0.21	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.24	0.77	0.26	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	14.51	0.73	0.24	0.00	0.24	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	12.83	2.24	0.00	0.00	0.00	0.00	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	8.54	1.18	0.00	0.00	0.29	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	23.72	2.09	0.52	0.00	0.00	0.00	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	51.20	8.00	3.66	0.91	1.37	0.91	1.60	1.14	0.00
clear cell carcinoma cell line:TEN	10636-108I6	42.16	14.75	1.39	0.69	0.69	0.69	0.87	0.17	0.35
colon carcinoma cell line:CACO-2	10513-107D9	23.61	10.07	0.55	0.00	0.37	0.00	0.37	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	27.37	1.90	1.52	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	69.02	14.28	0.00	1.19	0.00	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	70.38	16.57	0.47	0.24	0.82	1.65	0.24	0.12	0.12
colon, fetal, donor1	10070-101I7	60.56	6.80	0.62	0.00	0.00	0.62	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	385.02	155.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	76.49	10.20	0.00	0.42	0.00	0.00	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	48.45	8.00	1.36	0.00	0.15	0.60	0.30	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	50.34	10.15	0.99	0.00	0.28	0.14	0.42	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	273.86	37.92	3.54	1.77	1.66	1.66	0.55	0.55	0.22
cruciate ligament, donor2	10295-104G7	75.37	21.07	8.10	0.81	0.81	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	68.22	6.42	1.61	0.80	0.00	0.00	0.80	0.00	1.61
diencephalon, adult	10193-103E4	344.86	38.88	6.48	2.16	1.68	4.80	4.32	2.64	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	28.70	2.98	0.46	0.69	0.69	1.15	0.46	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	84.88	17.18	1.28	0.26	0.00	0.00	0.26	1.03	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.29	2.89	0.96	0.24	0.00	0.72	0.48	0.24	0.24
ductus deferens, adult	10196-103E7	112.62	21.93	3.99	1.50	3.99	0.50	2.49	0.00	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	92.17	17.28	1.44	0.00	1.44	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.23	8.83	1.47	0.00	0.74	1.47	2.21	0.00	0.00
dura mater, adult, donor1	10041-101F5	124.21	27.67	1.32	0.74	0.91	1.40	0.17	0.74	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.32	3.33	0.22	0.22	0.22	0.89	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	14.33	3.44	0.72	0.00	0.14	0.00	0.00	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	59.20	15.42	0.00	0.00	0.62	0.00	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	59.03	9.38	0.91	0.91	0.00	0.00	0.61	1.21	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	44.46	7.41	0.31	0.00	0.31	0.31	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	57.79	3.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	57.65	6.37	0.67	0.67	0.34	0.00	0.34	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	69.23	10.87	2.36	0.36	0.72	0.54	0.72	0.36	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	22.35	1.29	1.61	0.48	0.32	0.00	0.48	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	21.01	8.67	0.33	0.00	0.00	0.00	0.11	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.54	6.49	0.11	0.00	0.00	0.00	0.11	0.00	0.00
epididymis, adult	10197-103E8	102.56	15.28	2.51	0.42	1.05	2.51	2.51	0.84	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	57.48	4.61	3.19	0.89	1.24	0.18	0.89	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.95	1.18	0.39	0.39	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	4.98	1.44	0.26	0.13	0.13	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	5.22	1.08	0.00	0.00	0.20	0.10	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	6.27	1.34	0.11	0.00	0.00	0.00	0.22	0.00	0.00
esophagus, adult, pool1	10015-101C6	51.07	13.80	0.85	0.21	0.42	0.53	0.11	0.11	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	63.62	8.02	0.63	0.63	0.63	0.38	0.00	0.25	0.25
eye - muscle inferior rectus, donor1	10272-104E2	82.10	28.97	19.32	12.07	7.24	0.00	0.00	0.00	9.66
eye - muscle lateral, donor2	10298-104H1	63.13	8.42	2.10	4.21	0.00	2.10	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	107.15	14.88	5.95	1.49	0.00	0.00	1.49	1.49	4.46
eye - muscle superior, donor2	10297-104G9	66.50	24.08	3.44	2.29	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	88.90	13.12	1.46	0.00	0.00	0.00	2.91	0.00	2.91
eye, fetal, donor1	10054-101G9	74.49	14.24	1.53	1.27	1.02	1.53	0.51	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	62.83	8.72	0.51	0.26	0.51	0.26	0.26	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.44	6.17	0.47	0.00	0.00	0.00	0.24	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	979.52	149.46	22.05	7.69	9.10	3.85	5.07	2.35	2.44
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	23.72	7.51	2.70	0.30	0.00	0.30	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	50.38	16.00	0.55	0.09	0.27	0.09	0.00	0.09	0.18
gall bladder, adult	10198-103E9	71.46	13.04	0.48	0.24	0.97	0.97	0.48	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	128.85	63.89	2.68	0.54	0.54	0.54	0.54	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	129.23	69.47	2.61	1.12	0.75	0.37	1.12	1.12	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	38.44	13.94	1.90	0.42	1.06	1.06	1.06	0.42	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	31.53	2.13	0.97	0.39	0.39	0.19	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	19.67	1.64	0.49	0.16	0.00	0.00	0.00	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	74.13	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	17.13	4.80	0.46	0.23	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	11.82	1.26	0.69	0.00	0.23	0.00	0.23	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	33.03	2.80	0.28	0.00	0.28	0.42	0.28	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	7.48	7.23	1.00	0.00	0.00	0.25	0.50	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	125.61	38.84	2.74	0.74	1.37	0.84	0.42	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	137.07	44.38	2.95	1.69	0.70	0.70	1.40	0.84	0.14
glioblastoma cell line:T98G	10485-107A8	30.68	5.85	0.66	0.11	0.33	0.00	0.33	0.44	0.11
glioma cell line:GI-1	10413-106B8	27.82	4.10	0.88	1.17	0.29	0.00	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	505.14	67.06	16.04	18.22	9.48	7.29	2.19	0.00	2.92
globus pallidus, adult, donor10252	10161-103A8	347.35	25.39	12.94	12.20	3.17	2.20	1.22	3.17	3.17
globus pallidus, adult, donor10258	10367-105F7	313.55	15.06	15.06	5.48	2.74	1.37	4.11	5.48	0.00
globus pallidus, newborn, donor10223	10364-105F4	244.61	20.78	2.66	2.66	2.13	1.07	2.66	0.53	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	269.19	163.96	0.00	0.00	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.60	8.96	0.64	0.32	0.64	0.64	0.00	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	23.87	4.13	1.84	0.46	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	31.09	4.12	0.46	1.37	0.46	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.81	3.22	1.29	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	11.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	14.40	0.00	0.00	0.00	0.69	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	455.73	67.31	14.35	11.03	7.72	8.83	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	68.39	7.47	2.30	0.57	0.86	1.44	0.57	0.29	0.57
heart - mitral valve, adult	10205-103F7	101.35	28.40	4.48	2.09	2.39	0.90	0.90	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	89.42	20.40	8.37	4.45	0.78	0.52	3.40	0.52	1.31
heart - tricuspid valve, adult	10207-103F9	108.24	20.82	1.67	1.67	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	59.99	11.43	1.22	0.82	0.41	0.20	0.20	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	94.11	15.76	3.41	0.43	0.85	0.43	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	80.95	16.79	0.00	0.46	0.69	0.00	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	66.13	6.47	0.62	0.41	0.62	0.10	0.31	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	76.82	15.43	0.62	1.54	0.62	0.00	0.62	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	1.19	1.19	0.00	0.00	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	7.96	0.11	0.11	0.00	0.11	0.00	0.22	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	8.62	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	9.30	0.91	0.00	0.00	0.51	0.00	0.00	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	33.36	8.23	0.33	0.44	0.11	0.11	0.56	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	58.29	6.73	0.90	0.60	0.30	0.30	0.60	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	1031.50	157.09	47.32	29.34	17.03	7.57	3.79	2.84	10.41
hippocampus, adult, donor10252	10153-102I9	1018.25	54.49	62.66	58.37	21.02	8.37	7.55	9.18	11.02
hippocampus, adult, donor10258	10374-105G5	896.31	129.47	13.44	23.40	15.44	6.47	3.49	1.99	1.49
hippocampus, newborn, donor10223	10363-105F3	720.11	119.49	9.87	4.58	6.34	11.28	4.58	1.06	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.82	1.83	0.61	0.00	0.00	0.00	0.00	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	17.28	1.37	0.39	0.20	0.00	0.00	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	15.74	2.54	0.51	1.27	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	25.94	1.13	0.00	0.00	0.56	0.00	1.13	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.34	2.07	1.55	0.77	1.03	1.03	0.26	0.26	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.40	2.28	0.76	0.00	0.00	0.38	0.76	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	56.35	6.13	0.88	0.00	0.00	1.17	1.17	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	68.08	6.46	2.59	0.00	0.65	1.72	0.43	0.86	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	46.30	5.00	0.83	1.25	0.00	1.25	1.25	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	46.88	9.71	0.47	0.24	0.00	0.47	0.95	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	50.95	6.75	1.13	0.00	0.80	1.45	0.32	0.64	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	49.82	8.08	0.00	0.00	0.00	0.67	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	14.40	1.25	0.47	0.00	0.00	0.47	0.16	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.28	1.47	0.00	0.00	0.49	0.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	0.00	0.00	0.87	0.00	0.00	1.75	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	38.95	1.34	0.76	0.00	0.57	0.76	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	38.81	3.92	0.87	0.00	0.00	0.00	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	32.98	0.00	2.00	1.00	1.00	0.00	0.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	90.43	5.09	1.51	0.19	1.70	2.26	0.57	0.75	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	84.12	7.28	1.36	0.45	4.55	1.82	0.91	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	81.44	4.39	2.82	1.25	1.25	2.82	2.51	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	63.69	7.19	1.80	0.98	0.98	1.80	0.98	0.65	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	60.67	7.55	2.03	0.87	0.87	2.32	0.87	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	72.94	7.47	3.59	0.60	1.20	0.90	1.20	0.90	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.92	0.92	1.29	0.00	0.37	0.18	1.11	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	17.97	2.57	0.86	0.29	0.00	0.00	0.00	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	17.97	0.82	1.22	0.00	0.00	0.41	0.82	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	30.63	4.58	0.70	0.00	1.41	1.41	0.35	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	29.77	3.48	0.32	0.32	0.32	1.27	0.00	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	36.31	0.91	0.91	0.00	0.30	0.91	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	73.43	9.31	1.03	0.00	0.52	0.52	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	66.42	6.64	0.00	0.66	0.00	0.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	46.95	6.67	0.26	0.00	0.26	0.77	0.26	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	51.64	7.16	1.53	0.51	0.26	0.77	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	53.76	10.60	1.51	0.76	0.76	0.76	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.44	7.73	1.01	0.00	1.01	1.01	2.02	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	15.94	1.69	0.72	0.24	0.00	0.24	0.48	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	11.59	2.67	1.34	1.34	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	18.05	3.41	1.46	0.00	0.98	0.00	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	31.78	0.92	1.83	0.00	0.31	0.61	0.92	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	0.00	0.00	0.00	0.00	0.00	16.27	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	21.51	1.32	0.99	0.66	0.99	0.33	1.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	53.09	4.38	0.00	0.55	0.00	0.55	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	64.05	7.24	1.45	0.00	0.00	0.72	0.36	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	49.82	4.27	0.71	0.36	0.00	0.36	0.71	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	29.83	8.35	3.58	0.00	0.00	1.19	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	52.00	10.16	0.95	0.41	0.54	0.41	0.41	0.68	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	44.99	8.08	1.35	0.00	0.27	0.27	1.62	1.08	0.00
immature langerhans cells, donor1	11904-125F5	106.79	23.00	0.97	0.73	0.73	1.21	0.97	0.73	0.24
immature langerhans cells, donor2	11905-125F6	144.96	44.36	3.17	1.58	0.00	5.54	2.38	0.79	0.00
insula, adult, pool1	10039-101F3	1269.03	184.63	16.84	7.76	8.33	6.44	3.41	1.99	1.51
keratoacanthoma cell line:HKA-1	10791-110H8	8.45	3.90	0.00	0.00	0.00	0.00	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	48.06	9.51	1.30	0.40	0.00	0.40	0.10	0.20	0.10
kidney, fetal, pool1	10045-101F9	39.82	6.72	0.42	0.14	0.14	0.21	0.00	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	218.85	69.16	5.54	0.99	0.85	0.43	0.57	0.71	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	37.19	19.91	1.80	0.41	0.83	0.41	0.00	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	35.05	5.69	0.37	0.37	0.18	0.37	0.18	0.18	0.00
left atrium, adult, donor1	10079-102A7	81.73	11.99	2.18	0.00	1.63	1.09	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	78.38	14.66	1.01	2.02	0.51	1.01	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	23.53	1.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	33.77	10.06	0.36	0.36	0.00	0.72	0.72	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	39.67	11.41	1.09	0.00	1.63	1.63	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	27.44	5.83	1.94	0.24	0.49	0.73	0.73	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	44.45	0.00	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	61.69	11.50	0.00	0.00	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	54.78	8.85	0.94	0.12	0.00	0.35	0.12	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	40.30	4.53	1.56	0.16	0.31	0.47	0.16	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	78.95	9.02	0.73	0.61	0.12	0.24	0.00	0.12	0.12
liver, adult, pool1	10018-101C9	35.65	9.24	0.97	0.65	0.65	0.32	0.16	0.16	0.00
liver, fetal, pool1	10086-102B5	13.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	388.77	46.81	13.56	18.52	7.44	3.35	2.04	1.02	2.04
locus coeruleus, adult, donor10252	10165-103B3	336.07	40.42	13.66	16.06	4.43	3.88	2.77	2.03	3.32
locus coeruleus, adult, donor10258	10375-105G6	533.81	90.00	16.65	9.59	11.29	12.41	9.03	3.10	2.26
locus coeruleus, newborn, donor10223	10362-105F2	139.65	32.81	20.19	9.67	5.47	2.52	4.63	0.42	3.36
lung adenocarcinoma cell line:A549	10499-107C4	64.49	12.32	0.97	0.42	0.14	0.28	0.28	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	147.53	49.64	0.00	0.00	0.69	0.69	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	223.82	25.57	3.30	2.11	2.24	1.05	0.40	1.19	0.13
lung, adult, pool1	10019-101D1	81.63	19.73	1.54	0.35	0.59	0.47	0.12	0.24	0.12
lung, fetal, donor1	10068-101I5	73.64	24.26	2.00	0.86	1.43	0.86	0.00	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	132.42	19.70	5.50	2.29	2.29	3.67	1.83	0.92	0.92
lymph node, adult, donor1	10077-102A5	102.72	14.20	0.00	1.89	0.95	0.95	0.95	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	114.85	16.66	2.41	0.66	0.22	1.10	0.66	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	47.54	6.04	1.51	0.30	0.15	0.75	0.15	0.30	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	18.69	0.85	0.00	0.85	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	75.03	5.33	0.00	0.00	0.00	0.89	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	55.20	3.11	0.42	0.00	0.00	0.42	0.21	0.00	0.00
mature adipocyte, donor3	12233-129G1	55.24	4.50	0.24	0.24	0.00	0.47	0.00	0.00	0.47
mature adipocyte, donor4	12234-129G2	42.38	2.90	0.26	0.00	0.00	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	99.35	21.21	0.95	0.48	0.48	0.48	0.24	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	816.69	119.57	31.58	10.15	13.54	5.64	10.15	6.77	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	814.70	57.75	30.90	42.48	12.32	6.25	5.89	3.13	4.60
medial frontal gyrus, adult, donor10258	10368-105F8	665.87	118.18	25.10	11.44	7.94	4.77	10.48	1.27	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	179.98	21.32	26.02	13.22	5.97	8.10	9.81	2.13	3.84
medial temporal gyrus - adult, donor10196	10183-103D3	946.69	110.36	77.96	47.93	72.06	10.97	19.41	23.63	7.76
medial temporal gyrus, adult, donor10252	10156-103A3	769.53	52.84	54.33	57.94	21.43	3.18	5.31	5.31	11.25
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	768.58	88.61	17.34	13.48	11.56	3.85	11.56	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	200.95	28.71	258.37	114.83	14.35	0.00	71.77	14.35	86.12
medial temporal gyrus, newborn, donor10223	10353-105E2	675.51	76.81	21.89	5.38	6.82	4.31	6.46	1.08	3.95
medulla oblongata - adult, donor10196	10174-103C3	236.23	30.50	8.44	7.14	3.24	1.95	1.95	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	218.12	26.94	9.75	6.50	2.79	1.24	2.17	0.77	1.55
medulla oblongata, adult, pool1	10038-101F2	337.37	60.89	4.82	3.75	1.96	1.63	0.82	0.41	0.98
medulla oblongata, newborn, donor10223	10361-105F1	135.40	29.86	6.60	3.47	2.78	1.04	2.08	0.69	1.04
medulloblastoma cell line:D283 Med	10838-111E1	13.73	1.55	0.00	0.00	0.22	0.00	0.22	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	122.40	33.14	1.10	0.12	0.98	0.73	0.24	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	24.01	6.18	0.43	0.14	0.14	0.43	0.14	0.14	0.00
melanoma cell line:G-361	10465-106H6	43.71	20.36	3.53	0.81	0.81	0.27	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	103.48	21.35	4.52	0.72	1.09	1.99	2.53	0.36	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	28.20	2.64	0.88	0.88	0.88	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	39.14	4.93	0.52	0.00	0.52	0.52	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	31.30	5.83	1.99	0.00	0.31	0.31	0.61	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.09	4.36	0.55	0.00	0.55	0.36	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.81	7.45	0.41	0.00	0.00	0.83	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.07	6.74	1.12	0.00	0.14	0.00	0.70	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.03	10.59	0.77	0.19	0.39	0.19	1.16	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	40.26	19.43	1.39	0.69	0.00	0.00	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.51	9.27	0.34	0.17	0.34	1.03	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.76	4.03	0.69	0.35	0.12	0.23	0.35	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.15	5.44	0.53	0.53	0.27	0.00	0.27	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.01	7.70	0.27	0.14	0.14	0.27	0.81	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	25.61	7.40	0.85	0.71	0.28	0.14	0.28	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	37.88	14.82	2.31	0.00	0.33	0.00	1.98	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	33.21	7.89	0.83	0.00	0.00	0.00	0.28	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	52.36	21.64	2.79	0.70	0.00	0.00	0.70	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.91	12.25	2.45	0.82	0.41	0.20	1.43	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.49	12.22	0.36	0.72	0.72	0.36	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.69	7.34	0.52	0.10	0.31	0.31	0.62	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	26.68	11.63	0.91	0.23	0.46	0.23	0.46	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.85	8.81	0.42	0.42	0.42	0.00	0.42	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	28.54	9.56	1.05	0.45	0.30	0.30	0.60	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	29.59	9.63	1.93	0.44	0.61	0.35	0.88	0.26	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.55	7.36	0.74	0.74	0.00	0.37	1.47	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	43.50	12.88	2.58	1.14	0.29	0.00	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.42	5.05	2.11	0.84	1.26	0.00	1.68	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.90	5.02	0.46	1.37	0.46	1.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.88	4.35	0.00	0.00	0.26	0.00	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	23.82	3.66	1.05	0.26	0.00	0.00	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.49	4.01	1.23	0.00	0.31	0.00	0.92	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.53	6.12	0.24	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	23.35	2.37	1.02	0.34	0.00	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.86	2.36	0.79	0.00	0.00	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.61	5.56	0.00	0.00	0.46	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	24.23	7.21	0.58	0.00	0.00	0.00	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.19	4.91	0.22	0.00	0.22	0.00	0.45	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.15	5.05	0.00	0.24	0.48	0.24	0.48	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.93	2.93	0.00	0.00	0.00	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.46	6.04	0.67	0.00	0.00	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	18.42	4.91	0.41	0.00	0.41	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	21.48	4.30	0.43	0.00	0.00	0.43	0.43	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	8.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	5.16	0.00	5.16	5.16	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.89	2.92	0.32	0.00	0.00	0.00	0.32	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.99	3.20	0.53	0.00	0.00	1.07	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.89	2.45	0.00	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.16	4.66	0.00	0.00	0.00	0.39	1.17	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	2.10	0.00	0.00	0.00	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	2.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	4.74	0.59	0.00	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	4.87	0.00	0.00	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	5.70	0.00	0.63	0.00	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	18.28	3.45	0.34	0.00	0.34	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	2.15	0.00	0.00	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	0.00	0.00	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	9.37	1.22	0.00	0.00	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	2.38	0.79	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	9.43	0.59	0.59	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.04	1.56	0.00	0.00	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	1.34	0.00	0.00	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	5.14	2.57	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	2.07	0.00	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.85	0.49	0.49	0.00	0.00	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	0.00	0.00	0.00	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	3.18	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.27	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	1.82	0.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	1.65	0.00	0.82	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	18.85	1.79	0.00	0.00	0.00	0.00	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.77	1.30	0.32	0.00	0.32	0.32	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	24.45	0.00	0.00	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	65.77	27.08	0.00	0.77	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	61.66	8.03	0.94	0.24	0.47	0.47	0.24	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.78	3.48	0.70	0.46	0.23	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	12.12	4.73	2.26	0.10	0.10	0.00	0.31	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	36.77	8.62	1.13	0.45	0.45	0.45	0.45	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	42.05	8.07	1.96	0.49	0.98	0.24	0.24	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	40.52	9.74	1.55	0.66	0.66	0.22	0.44	0.00	0.44
mesothelioma cell line:Mero-82	10853-111F7	24.44	4.99	1.84	0.53	0.53	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	40.85	6.64	0.51	0.85	0.17	0.51	0.00	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	18.96	5.56	1.01	0.76	0.00	0.00	0.76	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	18.84	3.93	0.62	0.21	0.00	0.62	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	19.22	3.15	1.33	0.66	0.17	0.00	0.00	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	15.57	1.81	0.36	0.18	0.18	0.18	0.18	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	38.61	6.83	1.02	0.17	0.34	0.68	0.17	0.51	0.34
mesothelioma cell line:NCI-H28	10845-111E8	27.48	5.34	1.53	0.76	0.25	0.25	0.51	0.00	0.25
mesothelioma cell line:No36	10857-111G2	21.86	1.30	0.00	0.65	0.00	0.33	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	36.31	10.57	0.81	0.27	0.54	0.54	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	32.43	6.91	1.54	0.58	0.00	0.96	0.38	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	54.71	8.91	0.61	0.73	0.00	1.10	0.12	0.61	0.12
migratory langerhans cells, donor3	11903-125F4	88.84	11.85	1.44	0.90	0.00	1.08	1.26	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	48.97	3.26	4.24	2.61	2.61	0.65	1.96	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	51.71	10.60	1.48	0.42	0.42	0.42	0.42	0.00	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	213.77	22.81	0.92	2.07	1.61	0.69	0.69	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	90.58	11.61	0.95	0.95	0.38	0.38	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.40	7.95	0.37	0.18	0.00	0.37	0.18	0.18	0.00
myeloma cell line:PCM6	10474-106I6	66.02	15.62	2.17	0.79	0.79	0.79	0.99	0.00	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	32.97	7.10	0.00	1.01	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	43.35	6.28	1.37	0.00	0.59	0.00	0.59	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	14.49	4.68	0.22	0.11	0.11	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.87	5.81	0.22	0.00	0.07	0.07	0.00	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	14.90	8.83	0.00	0.55	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	101.46	15.41	3.45	1.84	0.46	2.07	0.23	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	102.90	13.84	2.25	0.56	0.94	2.06	0.37	0.75	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	11.18	1.05	0.00	0.21	0.00	0.00	0.00	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	76.78	8.39	1.68	0.56	0.19	0.93	1.12	0.19	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.62	2.61	1.19	0.00	0.24	0.24	0.24	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	18.53	0.16	0.16	0.00	0.16	0.16	0.48	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	28.98	1.41	0.81	0.00	0.00	0.20	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	32.42	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	44.98	4.52	0.00	0.00	0.00	0.00	0.27	0.00	0.27
neutrophil PMN, donor1	12133-128D9	74.37	59.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	19.11	2.71	0.00	0.17	0.00	0.17	0.17	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	106.47	8.81	0.80	0.00	0.00	4.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	39.43	8.98	2.24	0.00	0.64	0.96	0.96	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	34.68	10.51	2.36	0.00	0.26	1.58	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	1012.19	140.14	14.06	8.25	6.19	3.84	2.44	2.25	1.69
occipital cortex - adult, donor10196	10172-103C1	873.60	113.32	14.42	14.42	16.48	8.24	0.00	6.18	6.18
occipital cortex, adult, donor10252	10163-103B1	714.11	38.38	43.21	40.79	13.69	6.98	5.37	4.56	8.59
occipital cortex, newborn, donor10223	10355-105E4	675.12	58.23	14.19	3.64	4.37	4.37	4.37	1.46	3.64
occipital lobe, adult, donor1	10076-102A4	1112.57	115.46	21.25	16.27	9.45	31.49	9.71	10.50	3.94
occipital lobe, fetal, donor1	10073-102A1	474.58	33.47	14.16	9.44	4.72	10.30	12.44	4.29	6.87
occipital pole, adult, pool1	10036-101E9	737.40	97.13	5.99	3.31	2.92	2.21	1.26	0.79	0.63
olfactory region, adult	10195-103E6	672.89	89.41	31.33	27.51	10.32	4.78	7.45	2.87	5.73
optic nerve, donor1	10277-104E7	234.12	26.01	6.00	2.00	0.00	2.00	12.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.99	20.05	1.14	0.34	0.46	0.11	0.46	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.19	0.96	0.00	0.00	0.14	0.00	0.14	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.84	7.79	1.35	0.17	0.17	0.17	0.34	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	27.14	5.20	0.35	0.35	0.35	0.12	0.12	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	77.31	24.11	2.94	0.59	0.29	0.88	0.59	2.06	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	86.89	17.75	1.87	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	11.24	2.54	0.00	0.21	0.21	0.00	0.21	0.21	0.21
ovary, adult, pool1	10020-101D2	77.74	16.95	1.05	0.09	0.09	0.70	0.09	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	218.70	26.40	4.22	1.83	1.83	2.02	0.92	0.18	0.55
pancreas, adult, donor1	10049-101G4	48.91	3.76	1.88	1.88	0.00	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	25.72	7.55	0.28	0.28	0.00	0.00	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	36.11	14.82	2.90	0.51	0.34	0.34	1.53	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	134.95	21.03	1.66	0.17	0.99	0.66	0.50	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	923.55	121.54	13.64	6.04	6.22	3.66	4.21	2.11	1.46
parietal cortex, adult, donor10258	10373-105G4	511.60	69.73	15.41	19.82	13.21	1.47	4.40	2.20	1.47
parietal lobe - adult, donor10196	10171-103B9	602.85	83.70	35.74	15.99	10.35	2.82	2.82	3.76	3.76
parietal lobe, adult, donor10252	10157-103A4	686.94	62.99	37.05	44.75	11.40	6.56	7.41	5.13	4.56
parietal lobe, adult, pool1	10034-101E7	915.92	123.63	11.81	5.64	5.02	3.61	1.94	1.41	0.88
parietal lobe, fetal, donor1	10072-101I9	330.71	23.28	25.22	10.67	7.76	8.73	10.67	1.94	1.94
parietal lobe, newborn, donor10223	10356-105E5	575.74	59.82	26.92	8.22	8.97	4.11	8.60	2.24	3.74
parotid gland, adult	10199-103F1	56.73	4.93	2.47	0.00	0.62	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	82.18	16.11	5.91	4.83	1.61	0.54	4.30	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	29.94	3.90	0.37	0.74	0.19	0.56	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	63.09	9.91	1.17	0.29	0.29	0.15	0.15	0.58	0.00
pineal gland - adult, donor10196	10179-103C8	283.81	93.53	16.77	20.64	5.81	3.23	1.94	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	272.42	108.97	14.81	11.84	0.59	1.18	2.37	0.00	1.78
pineal gland, adult, donor10258	10377-105G8	283.44	70.23	15.05	10.03	3.14	1.25	0.63	2.51	2.51
pituitary gland - adult, donor10196	10180-103C9	286.34	59.70	8.09	2.02	1.01	4.05	2.02	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	421.11	90.16	14.07	1.04	3.13	5.21	3.65	2.08	2.08
pituitary gland, adult, donor10258	10378-105G9	280.91	38.31	16.17	5.96	6.81	0.85	5.96	2.55	0.00
placenta, adult, pool1	10021-101D3	43.00	48.59	0.65	0.75	0.11	0.54	0.54	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	45.16	5.16	1.59	1.32	0.53	0.79	0.13	0.40	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	93.54	32.37	1.56	0.31	0.47	0.78	0.62	0.31	0.16
pons, adult, pool1	10033-101E6	412.95	109.05	8.00	3.87	3.01	2.67	1.20	0.86	0.77
postcentral gyrus, adult, pool1	10032-101E5	823.81	114.81	11.33	3.05	4.79	3.40	2.35	1.83	1.31
promyelocytes/myelocytes PMC, donor1	12132-128D8	23.01	10.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	39.47	6.99	1.17	0.58	0.29	0.58	0.58	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	95.47	12.89	2.36	0.73	0.91	0.73	0.73	0.73	0.36
prostate, adult, pool1	10022-101D4	85.89	14.33	0.91	0.18	0.18	0.45	0.54	0.09	0.09
putamen, adult, donor10196	10176-103C5	1064.41	135.03	30.45	21.48	10.39	9.68	9.91	3.78	5.90
putamen, adult, donor10252	10152-102I8	605.86	39.21	17.65	47.06	23.53	15.69	5.88	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	514.71	26.23	8.74	10.93	3.28	3.28	3.28	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	789.83	57.26	19.09	9.18	6.77	4.59	2.66	3.87	1.93
putamen, newborn, donor10223	10365-105F5	123.69	22.49	16.49	6.75	3.75	2.25	4.50	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	64.30	12.22	0.87	0.87	0.87	0.87	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	118.23	13.91	1.39	1.39	1.39	1.39	1.39	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	38.37	7.21	0.64	0.64	0.21	0.21	0.64	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	77.04	10.77	3.73	3.31	2.07	0.00	4.14	0.83	0.83
retina, adult, pool1	10030-101E3	122.56	31.31	2.19	0.60	1.29	0.40	0.50	0.30	0.20
retinoblastoma cell line:Y79	10475-106I7	27.28	2.08	1.30	0.26	0.26	0.00	0.26	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.68	2.83	0.74	0.37	0.25	0.00	0.12	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	41.62	1.12	1.41	0.00	0.00	0.00	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	30.31	5.30	0.00	0.00	0.76	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	18.78	8.42	0.65	0.16	0.32	0.16	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	20.93	7.30	1.38	0.14	0.14	0.28	0.28	0.00	0.00
salivary acinar cells, donor3	11773-123I9	43.03	30.45	0.66	1.32	0.00	0.00	1.32	0.66	0.66
salivary gland, adult, pool1	10093-102C3	42.90	10.30	1.14	0.00	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.93	8.52	1.18	0.25	0.25	0.08	0.34	0.08	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	34.91	7.17	1.29	0.12	0.00	0.35	0.35	0.00	0.00
seminal vesicle, adult	10201-103F3	111.10	24.87	3.70	2.65	1.06	2.65	1.59	2.12	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	47.13	13.36	2.19	0.73	0.73	0.49	0.49	0.49	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	43.53	5.03	0.75	0.00	0.50	0.50	0.75	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	35.12	8.03	2.01	0.00	1.00	1.00	2.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	47.68	12.76	2.28	0.94	0.81	0.13	0.54	0.40	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	27.52	6.41	0.99	0.11	0.22	0.22	0.11	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	41.80	6.45	0.65	0.26	0.39	0.52	0.52	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	45.40	4.26	5.67	1.42	0.00	0.00	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	49.77	7.92	1.08	0.24	0.00	0.60	0.36	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	33.17	4.02	0.00	0.00	0.00	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	67.85	27.14	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	53.02	8.84	0.63	0.63	0.00	0.63	0.63	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	25.68	1.67	0.67	0.33	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	62.10	18.60	4.41	2.21	2.84	0.00	0.32	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	24.09	1.73	1.16	0.58	0.00	0.19	0.77	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	18.46	2.80	0.82	0.00	0.00	0.00	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.47	1.93	0.48	0.32	0.32	0.16	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	102.64	16.34	4.14	0.65	0.87	0.87	0.87	1.09	0.00
small intestine, adult, pool1	10024-101D6	99.50	23.05	2.27	0.96	0.84	1.43	0.24	0.24	0.00
small intestine, fetal, donor1	10064-101I1	48.65	6.39	1.97	0.74	0.74	0.25	0.98	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	52.83	14.87	2.05	0.00	0.51	0.51	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	86.07	12.66	2.07	1.03	1.29	0.78	0.78	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	191.64	34.84	1.34	0.54	0.27	1.07	0.54	0.27	0.80
spinal cord - adult, donor10196	10181-103D1	298.23	36.02	10.09	13.53	4.36	2.29	1.84	1.38	2.29
spinal cord, adult, donor10252	10159-103A6	212.51	35.88	7.89	4.73	3.15	1.97	1.97	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	116.22	14.53	6.92	7.61	3.46	2.08	2.77	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	238.45	24.39	7.93	4.88	1.22	4.88	1.83	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	85.41	11.48	5.97	3.21	0.46	0.92	2.76	0.00	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	49.14	8.66	0.45	0.30	0.30	0.15	0.15	0.15	0.15
spleen, adult, pool1	10025-101D7	66.52	12.22	0.66	0.55	0.33	0.33	0.33	0.11	0.22
spleen, fetal, pool1	10044-101F8	43.38	7.31	0.32	0.24	0.00	0.16	0.00	0.00	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	52.69	6.42	1.55	0.21	0.31	0.62	0.10	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.17	14.62	0.95	0.57	0.38	0.19	0.76	0.38	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	27.26	6.64	1.05	0.00	1.05	0.35	0.70	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	149.73	17.20	2.74	0.39	1.17	1.56	2.35	0.00	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	610.52	114.70	18.12	6.75	4.28	2.70	5.52	3.94	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	110.98	9.74	2.54	0.85	0.00	1.27	1.27	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	59.23	7.19	0.85	1.27	0.42	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	88.64	10.68	0.00	1.07	1.07	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	55.26	8.55	1.14	0.57	0.00	1.71	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	325.64	108.55	488.47	162.82	54.27	0.00	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	146.64	21.81	6.02	2.49	3.12	1.04	2.28	1.04	0.62
substantia nigra, adult, donor10258	10371-105G2	407.59	97.24	13.97	10.35	7.24	4.14	1.03	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	97.51	28.26	7.07	3.53	3.53	1.41	0.71	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	44.71	3.44	1.38	0.00	0.23	0.46	0.46	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	816.26	114.27	10.60	3.81	4.41	3.14	1.95	1.19	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	553.43	25.64	14.96	8.55	3.56	15.67	4.99	6.41	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	340.20	24.17	14.07	7.91	3.96	4.83	6.59	5.27	1.76
tenocyte, donor1	11763-123H8	38.40	10.82	0.70	0.70	1.05	0.35	0.70	0.70	0.35
tenocyte, donor2	11765-123I1	54.56	26.32	3.05	0.76	0.76	0.38	1.53	0.00	0.38
tenocyte, donor3	11768-123I4	38.18	10.01	2.97	0.74	1.48	0.00	2.22	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	42.32	6.80	0.85	0.51	0.85	0.34	0.51	0.00	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	125.32	7.09	2.47	0.92	0.46	1.54	0.62	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	43.86	4.65	1.24	0.00	0.31	0.46	0.31	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	69.82	12.19	1.02	0.51	0.51	0.76	0.38	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.82	6.05	1.51	0.38	0.38	0.00	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	45.48	12.54	0.76	0.22	0.44	0.44	0.55	0.11	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.61	3.91	0.65	0.00	0.00	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	48.53	12.03	0.86	0.32	0.32	0.75	0.11	0.00	0.00
testis, adult, pool2	10096-102C6	32.93	5.41	3.61	0.00	0.00	0.00	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	334.51	57.41	9.94	7.73	7.73	2.21	3.31	0.00	1.10
thalamus, adult, donor10252	10154-103A1	269.12	20.63	12.35	8.91	3.59	1.88	1.25	0.78	2.81
thalamus, adult, donor10258, tech_rep1	10370-105G1	583.52	44.65	12.32	18.48	13.86	1.54	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	430.17	55.01	21.24	15.48	18.12	5.76	15.48	2.47	3.79
thalamus, newborn, donor10223	10366-105F6	147.28	35.09	14.96	4.60	6.33	5.18	1.73	1.73	2.88
throat, adult	10209-103G2	61.67	9.49	0.75	1.00	0.25	1.75	0.00	0.25	0.25
throat, fetal, donor1	10061-101H7	62.77	7.01	1.22	1.52	0.91	0.91	0.30	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	22.26	0.40	0.00	0.00	0.20	0.00	0.40	0.00	0.00
thymus, adult, pool1	10027-101D9	38.27	3.08	0.40	0.00	0.10	0.50	0.20	0.10	0.00
thymus, fetal, pool1	10043-101F7	38.55	4.16	1.25	0.10	0.31	0.31	0.21	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	44.81	13.69	2.66	0.40	0.93	0.40	0.53	0.00	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	47.08	6.29	0.84	0.28	0.28	0.00	0.28	0.00	0.14
thyroid, adult, pool1	10028-101E1	71.01	14.46	0.84	0.28	0.56	0.28	0.37	0.00	0.00
thyroid, fetal, donor1	10060-101H6	81.47	13.45	3.95	2.11	1.05	0.00	0.79	0.53	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	95.47	27.72	6.16	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	54.19	17.21	1.40	0.70	1.40	0.70	0.47	0.70	0.47
tongue, fetal, donor1	10059-101H5	54.78	6.31	0.39	0.39	1.18	0.79	1.18	0.00	0.00
tonsil, adult, pool1	10047-101G2	94.37	15.93	0.70	0.10	0.20	0.40	0.20	0.30	0.00
trachea, adult, pool1	10029-101E2	66.34	19.14	0.74	0.00	0.33	0.90	0.16	0.49	0.08
trachea, fetal, donor1	10058-101H4	64.63	9.23	3.08	0.00	1.54	0.00	0.38	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	42.51	9.57	0.35	0.35	0.35	0.00	0.35	0.71	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	32.73	7.29	0.30	0.20	0.30	0.00	0.20	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	33.69	9.56	1.10	0.31	0.78	0.47	0.63	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	28.54	9.51	3.81	0.00	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	48.59	12.27	0.68	0.42	0.34	0.25	0.08	0.34	0.00
umbilical cord, fetal, donor1	10057-101H3	73.03	6.26	6.26	0.00	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	65.52	17.40	1.37	0.34	0.17	0.34	0.17	0.00	0.17
uterus, fetal, donor1	10055-101H1	58.87	6.66	1.02	0.00	1.54	1.02	0.00	0.51	0.51
vagina, adult	10204-103F6	82.07	21.32	0.00	0.00	0.00	1.94	0.65	0.65	0.00
vein, adult	10191-103E2	68.83	10.08	1.32	1.10	0.66	1.10	1.10	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	48.87	1.87	0.53	0.27	1.07	1.07	0.27	0.27	0.27